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1. SYNOPSIS  
 
 
Clinicians and researchers are increasingly interested in a better 
characterization of psychiatric disorders than that provided by the DSM IV-TR 
(Kupfer, 2005; Maj, 2005; Maser & Akiskal, 2002). Despite debates and 
different perspectives concerning diagnostic nomenclature have been vital in 
psychology and psychiatry through the last 40-50 years, the forthcoming DSM-
V is challenging the current categorical conceptualization.  New data emerging 
from basic and clinical neurosciences, genetics, cognitive and behavioural 
sciences, clinical research (rising issues such as that of “comorbidity”), as well 
as the increasing need to provide more sophisticated examination of 
development across the lifespan, have increased the debate on the essential 
need of incorporating a dimensional model directly into the diagnostic 
nomenclature. Inevitably, this process has also involved post-traumatic stress 
conditions, that have recently risen progressive interest after the emerging 
increasing rates of exposure to trauma in the general population, either related 
to urban or domestic violence, or to great disasters, such as happened for the 
Twin Towers terrorist attack, the Tsunami or the New Orleans hurricane. 
Post-Traumatic Stress Disorder (PTSD) is a severe and often chronic 
disorder with a typical onset following exposure to traumatic events (Kessler et 
al., 1995), that has been only recently carefully investigated in general 
population samples (Breslau et al., 1991; Kessler et al., 1995). Originally 
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described as a war related disorder it was first coded in DSM only in 1980 
(DSM-III) and its characteristics and diagnostic criteria have been 
progressively defined, both for what concerns the definition of the trauma and 
of the symptomatology. Current diagnostic criteria (DSM-IV-TR, 2000) 
stipulate exposure to an event that threatens serious physical injury or death, 
and that is accompanied by feelings of intense fear, helplessness, or horror, the 
diagnosis then requires development of symptoms in 3 domains, re-
experiencing, avoidance and hyperarousal, that persist for at least a month.  
Recently, investigators have emphasized the importance of a further 
evolution in the definition of whether the event is shocking to the individual or 
not, regardless of its form, in order to define it as traumatic, i.e. able to produce 
symptoms of traumatic stress (intrusion, numbing and arousal) (Galea et al., 
2005). Although greater degrees of trauma are expected to yield higher rates of 
PTSD than less extreme ones (Engdahl et al., 1997), increasing evidence 
documents the importance of the so-called “low-magnitude” events (e.g., 
divorce, serious illness and financial reverses) in determining post-traumatic 
stress reactions (Breslau & Davis, 1987; Solomon & Canino, 1990; Moreau & 
Zisook, 2002). Moreover, several studies reported significant functional 
impairment and seek for treatment in a large number of victims who, even if 
exposed to a DSM-IV-qualified trauma, did not fulfil all the other criteria (B,C 
and D) for PTSD (Stein et al., 1997; Marshall et al., 2001; Hepp et al., 2005), 
leading some authors to introduced the concepts of partial, subthreshold or 
subsyndromal PTSD, in order to better investigate the clinical relevance of 
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these forms (Weiss et al., 1992; Carlier & Gersons, 1995; Stein et al., 1997). In 
line with these data, a first multidimensional model approach to PTSD has 
been developed, exploring the symptom severity, the nature of the stressor and 
the possible responses to trauma (Moreau & Zisook, 2002). 
As part of an international collaboration project, named the “Spectrum 
Project”,  ongoing since 1995 between researchers form the University of Pisa 
(G.B. Cassano, L. Dell’Osso, M. Mauri), the Western Psychiatric Institute and 
Clinic of the University of Pittsburgh (E. Frank, D.J. Kupfer), the Columbia 
University of New York (J. Endicott, M.K. Shear) and of the University of 
California San Diego (J.D. Maser), a new concept of trauma and loss spectrum 
has been developed. This concept is based on a spectrum model (Cassano et al., 
1997) that emphasizes soft signs, low-grade symptoms, subthreshold 
syndromes, as well as temperamental and personality traits comprising the 
clinical and subsyndromal manifestations, that targets PTSD and prolonged 
grief disorder. This latest, also sometimes called Complicated Grief (CG), has 
been recently explored as an independent form of stress response (Prigerson et 
al., 1995, 1996; Horowitz et al., 1997).  
In line with an increasing number of studies interested in a better 
characterization of psychiatric disorders than that provided in DSM IV-TR 
(Kupfer, 2005; Maser & Akiskal, 2002), the “Spectrum Project” is aimed at 
developing and testing a set of instruments that assess a broad array of clinical 
features associated with different DSM conditions (Fagiolini et al., 1999; 
Cassano et al., 1999; Mauri et al., 2000; Dell’Osso et al., 2000; Dell’Osso et 
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al., 2002a, 2002b; Sbrana et al., 2003; Sbrana et al., 2005). The latest of this 
series of spectrum assessment is represented by the Structured Clinical 
Interview for Trauma and Loss Spectrum (SCI-TALS), whose development 
process and validation study is reported in the present thesis.  
When developing a spectrum assessment of this condition, we included 
a continuum of potentially triggering events, a range of symptoms that 
comprise an acute reaction, and an array of persistent symptoms. We also 
included loss events as highly stressful experiences capable of evoking a 
specific constellation of grief symptoms, in line with recent work identifying a 
syndrome of complicated grief as a form of stress response (Prigerson et al., 
1996; 1999; Horowitz et al 1997; Shear & Smith-Caroff, 2002; Langner & 
Maercker, 2005; Shear & Shair, 2005). The instrument includes two specific 
sections that apply the “spectrum” concept to the definition of the trauma: one 
exploring the exposure to a spectrum of losses, including either those of 
relatives or close friend or of important relationships or situations; the other 
exploring a spectrum of traumas ranging form DSM-IV-qualifying ones to less 
severe experiences. The items of the interview include, in addition to a subset 
of the DSM-IV criteria for PTSD, a number of features derived from clinical 
experience and from a review of the phenomenological descriptions of post-
traumatic syndromes including CG.  
Primary aim of the present thesis is to document the acceptability, 
reliability and validity of the Structured Clinical Interview for Trauma and 
Loss Spectrum (SCI-TALS), that was investigated through a national 
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multicenter validation study, involving 6 Italian Academic Departments of 
Psychiatry (Pisa, Cagliari, Milano, Napoli, Sassari and Siena), coordinated by 
the 2nd Psychiatric University Clinic of the University of Pisa (Prof. L. 
Dell’Osso, Dr. C. Carmassi). Study participants included a consecutive sample 
of 186 subjects, divided in three diagnostic groups (patients with PTSD, 
patients with CG and Controls), data from a sub-sample of 140 subjects, 
without comorbid diagnosis of PTSD and CG, were analyzed for the validation 
study of the SCI-TALS reported in the present thesis. The final sample 
included 48 consecutive patients with PTSD (DSM-IV-TR, 2000), 44 with CG 
(Prigerson et al., 1999), and 48 comparison individuals, without current or 
lifetime psychiatric history. All subjects were assessed by: SCID, for DSM-IV 
diagnosis (number of items endorsed in re-experiencing, avoidance and arousal 
criteria were listed), Impact of Event Scale, for PTSD severity, and Inventory 
of Complicated Grief, for CG diagnosis .  
Results showed that SCI-TALS significantly discriminated subjects 
with PTSD or CG from controls. As expected, the instrument did not 
discriminate between those with PTSD and CG, except on the domain of grief 
reactions. Validity and reliability of the instrument were confirmed as 
substantial and internal consistency was good. Acceptability was excellent. The 
SCI-TALS showed to be user friendly to both clinicians and patients.  
Besides progresses in clinical assessments, recent studies attempting to 
arrive at a clear-cut demarcation of the PTSD syndrome and to delineate clear-
cut diagnostic criteria for PTSD, have suggested the relevance of biological 
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markers of PTSD. Although the findings have been highly variable (de Kloet et 
al., 2006), a great number of data have suggested the presence of characteristic 
alterations in the function of hypothalamic-pituitary-adrenal (HPA) axis 
(Yehuda et al., 2000; Nemeroff et al, 2006), the network which coordinates 
steroid metabolism during the physiological responses. 
The steroid biosynthesis occurs mainly in the adrenal gland, but also in 
the brain glial cells, in which the so-called neurosteroids are synthesized. In 
both tissues, the pivotal limiting step in the synthesis is the cholesterol 
transport within mitochondria which is realized through a mitochondrial pore. 
The mitochondrial translocator protein (Peripheral Benzodiazepine Receptor, 
PBR), a protein complex mainly localized in the outer membranes of the 
mitochondria, has been demonstrated to be a component of such pore, essential 
for the cholesterol crossing through the outer mitochondrial membrane, 
behaving either as a channel or as a chaperon (Culty et al., 1999; Lacapere & 
Papadopoulos, 2003). 
The PBR density has been found altered in many psychiatric disorders 
(Papadopoulos et al, 2006) as well as in stress responses: up-regulation has 
been shown in acute stress conditions while down-regulation in repeated or 
chronic stress (Weizman et al., 1994; Gavish et al., 1996; Droogleever et al., 
2004; Veenman & Gavish, 2006).  
Studies on PTSD have investigated platelet PBR levels only in veteran 
populations during or after chronic war stress (Weizman et al., 1994; Gavish et 
al., 1996), in which lower receptor levels have been reported. 
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Since mitochondrial PBR is a key element in the steroidogenesis rate-
limiting step, and alterations in the HPA axis seem to represent a characteristic 
finding of PTSD patients, secondary aim of the present thesis was to explore 
lymphomonocyte mitochondrial PBR alterations in Italian civilian patients with 
PTSD (DSM-IV), exposed to non-combat related traumas, versus controls. 
Increasing data in the literature have shown higher vulnerability for 
PTSD development in patients with bipolar disorder (BD) (Otto et al., 2004), 
and authors are debating whether BD might represent a risk factor for PTSD 
(Pollack et al., 2006) or if this comorbidity might be due to the fact that 
patients with BD frequently present characteristics that have been identified as 
risk factors for PTSD, such as: trauma exposure (Darves-Bornoz et al., 1995; 
Mueser et al., 1998; Neria et al., 2002), depression and hypomania (Schnurr et 
al., 1993), comorbid anxiety disorders (Pollack et al., 2006). Recently Pollock 
and collaborators (Pollack et al., 2006), examining PTSD onset following 
indirect exposure to the September 11, 2001, terrorist attacks, in a cohort of 
patients with BD (enrolled in the on-going longitudinal study Systematic 
Treatment Enhancement Program for Bipolar Disorder, STEP-BD), have 
suggested the presence of manic state at the time of exposure as the most 
critical risk factor for the onset of persistent PTSD. 
Since increasing data have reported the possibility of a relevant 
correlation between the presence of a manic or hypomanic state during 
exposure to traumatic events and the subsequent onset of PTSD (Otto et al., 
2004), secondary aim of the present study was to investigate if the number of 
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lifetime manic/hypomanic spectrum symptoms reported by the patient could be 
correlated with PBR density decrease in civil patients with PTSD. Correlations 
between PBR changes and lifetime subthreshold mania in patients with PTSD 
diagnosis were investigated in order to corroborate the role of mood alterations 
as risk factors for adverse sequel following exposure to trauma. 
Until now, no difference has been reported in platelet PBR density of 
subjects with major depression, with respect to controls. Moreover, no studies 
are available about PBR in bipolar disorders, although abnormalities of the 
HPA axis functions are well documented in this psychiatric disorder (Gavish et 
al., 1999; Watson et al., 2004).   
Subjects enrolled for the national multicenter validation study at the 
Pisa site were asked to complete this second phase of the study. Patients who 
consented to participate gave a blood sample (16 ml) after all procedures were 
explained to them and a written consent was obtained. Blood samples were 
then processed to assess PBR binding characteristics in lymphomonocyte 
mitochondrial membranes. Patients were also assessed by the MOODS-SR 
(Dell'Osso et  al., 2002), a sharpened assessing the mood spectrum 
symptomatology. 
These results showed, for the first time, a significant decrease in 
mitochondrial PBR density in the lymphomonocytes of civilian trauma victims 
with diagnosis of PTSD with respect to controls, according to data obtained in 
war-related samples. PBR alterations presented a significant correlation to full-
blown Axis I PTSD diagnosis, enhancing the possible relevance of PBR for 
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diagnostic implications in PTSD. We did not also evidenced any correlation 
between the receptor density and IES scores, in line with previous findings 
(Weizman R. et al., 1994). Further, a significant correlation between PBR 
alterations and the presence of lifetime manic spectrum symptoms was found. 
We enhanced a significant correlation between PBR Bmax and total Mania 
values of the MOODS-SR. In particular, patients with PTSD presenting the 
highest number of lifetime manic/hypomanic items showed the lowest PBR 
density. This data corroborated the relevance of an accurate assessment of 
manic-hypomanic spectrum symptoms as risk factor for PTSD onset. 
In conclusion, post-traumatic stress conditions are showing increasing 
prevalence in the general population and subclinical and subsyndromal forms 
are showing their clinical relevance. The results of the present thesis 
demonstrate the validity of a new assessment instrument, the Structured 
clinical interview for Trauma and Loss Spectrum, corroborating the relevance 
of a spectrum approach to post-traumatic stress conditions, including CG. 
The SCI-TALS showed to be a valid and reliable instrument, able to 
provide a more specific description of patients’ clinical features giving 
information on a broad spectrum of trauma, loss events and related symptoms 
beyond those covered by existing instruments. A less restrictive approach to 
the definition of the potentially traumatic events than that defined in DSM-IV, 
as reported by SCI-TALS, would particularly help clinicians to more 
accurately explore post-traumatic stress conditions. Moreover, the evidence of 
a different profile for those suffering the consequences of trauma versus loss 
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suggests that the spectrum approach might help identify specific phenotypes to 
be used in clinical, neurobiological and genetic studies.  
Further, in line with studies enhancing the need for neurobiological 
markers for a better understanding of either full blown and subsyndromal 
forms, the significant decrease in platelet PBR levels found in civilian patients 
with PTSD supports a role for this biochemical parameter in clinical 
assessments. Moreover, the correlation between this alteration and the presence 
of lifetime manic spectrum symptoms enhances the possible role of  mood 
spectrum symptomatology on PTSD onset, and corroborates the relevance of 
an accurate assessment of manic-hypomanic spectrum symptoms as risk factors 
for PTSD onset.  
To our knowledge, this is the first study investigating PBR alterations 
in a group of civilian patients that reported a PTSD diagnosis not related to war 
traumas, comparing the receptor among subjects with chronic PTSD arisen 
after exposure to different types of traumas. Moreover, this is the first study in 
which PBR density determination was conduced only on mitochondrial 
membranes, assuring the PBR amount estimated is involved in the biosynthesis 
of steroids. 
Further studies are warranted to assess the potential utility of this 
spectrum  approach to PTSD and CG in clinical practice and to confirm the 
role of biological markers, such as PBR, in helping to increase the knowledge 
on the pathogenesis of these disorders.  
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2. INTRODUCTION  
 
  
STRESS AND PSYCHIATRIC ILLNESS 
 
 
Historically, the conceptualization of mental disorders had been 
ascribed to an imbalance in bodily humours, to the influence of external 
spiritual or other supernatural forces, and to moral or somatic deficiency. In the 
early nineteenth century, a new school of thought emerged in France, led by 
Philippe Pinel of the Salpetriere in Paris, and in the United States, led by 
Amariah Brigham, conceptualizing that the expression of mental illness was 
affected by life circumstances and, more broadly, by societal factors. These 
various influences were further elaborated an later converged in the bio-
psychosocial models. 
This orientation has progressively held to the modern concept that 
individual's response to stress can be modified and modulated by a number of 
intrinsic factors (e.g., genetic vulnerability, pre-morbid personality) and 
extrinsic factors (e.g., social support). Further models have incorporated 
individual temperamental and experiential characteristics, such as potential 
vulnerability (or resiliency) factors, stressful life events as initiating or 
exacerbating factors, and a variety of support networks as potentially 
modifying factors for the occurrence of mental illness. For the most part, this 
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multideterminate model of mental illness has dominated modern psychiatric 
thinking. Nevertheless, the current diagnostic nomenclature (the Diagnostic 
and Statistical Manual of Mental Disorders fourth edition revised, DSM-IV-
TR) does not emphasize this bio-psychosocial model of the nature and genesis 
of psychiatric disorders for its structure that is proposed to be descriptive and 
phenomenological. Thus, in DSM-IV-TR, major depression is major 
depression, whether it appears in the context of job loss, divorce, or for no 
apparent reason. There are interesting inconsistencies in this approach, for 
example when a major depressive episode occurs in the context of bereavement 
it may not be coded as major depression in accordance to DSM-IV-TR, as there 
is agreement on the fact that loss events may induce, in most case, depressive 
“like” reactions. Interestingly, we can argue whether if individuals develop 
major depression after the loss of their home as consequence of a traumatic 
event. In this case, according to DSM-IV-TR, it should rather be diagnosed as 
an adjustment disorder (if short-lived), but if persistent, then a diagnosis of 
major depression would apply. The question rises on weather the two episodes 
should be considered differently just as correlate with re provoking or 
triggering event. 
It is a given of human existence to be exposed to life-threatening 
events, and epidemiological studies confirm that a large majority of the 
population report such exposure. However, a substantial unlucky minority goes 
on to develop posttraumatic stress disorder (PTSD) and even if attention to this 
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debilitating condition has increased dramatically over the past decade, yet little 
is known on risk factors and psychopathology of PTSD. 
The recent increasing attention to PTSD rises the relevance of a new 
focus on the impact of life events over the development of psychopathology. 
The increased risk for exposure in the modern countries, besides the 
documented need for treatment required by people expressing subthreshold 
form of post-traumatic stress reactions increases the need for researches 
oriented to a new dimensional approach to these conditions.  
Although PTSD is another exception to the DSM-IV-TR rule that the 
nomenclature should be atheoretical (it is one of several disorders for which the 
occurrence of a stressful life event is pivotal for diagnosis), it has its own 
characteristic symptoms (e.g., reexperiencing symptoms), nevertheless, as it is 
happening for other disorders in the classification revision for the forthcoming 
DSM-V, multidimensional perspectives have been suggested to succeed 
struggling potentially stressful life events, acute reaction and persistent 
symptomatology into diagnosis.  
In line with the progresses in this increasingly actual debate, further 
research is needed in order to sharpen the thinking about the relationship 
between life events, stress and psychiatric illness.  
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POST-TRAUMATIC STRESS DISORDER (PTSD) 
 
 
        Diagnostic Evolution and Epidemiology 
 
The concept of Post-Traumatic Stress Disorder (PTSD) is well known 
nowadays, after its introduction in DSM-III in 1980 (APA, 1980). However, 
the relationship between life events and psychopathology has long been 
described in medicine, and many names and concepts have preceded the actual 
definition (Kinzie & Goetz, 1996).  
In the most recent centuries it’s possible to find descriptions of 
psychopathological reactions with a typical onset after exposure to a traumatic 
event that resemble the symptomatological features of what is now called 
PTSD (DSM-IV-TR, 2000).    
The first anecdotic evidences of post-traumatic reactions can be found 
around the sixteenth century and were described in relationship to combat 
events (Holmes, 1985); later on, symptoms related to non combat trauma have 
also been described. In 1666, in fact, a case of post-traumatic syndrome has 
been described as consequence of the Great London Fire (Daly, 1983); two 
centuries later, even the famous writer Charles Dickens seemed to have 
experienced many post-traumatic symptoms after having witnessed a railway 
accident outside London (Trimble, 1981).  
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In 1838, Esquirol already described, in his “Traitè des maladies 
mentales”, the possible role of certain life events as “moral” causes of mental 
illness in a systematic manner, enhancing the distinction between 
“psychological” and “physical” causes of insanity.   
Subsequently, many different names were reported in the medical 
literature in order to define the clinical states developed after trauma exposure: 
in 1867 Ericksen defined the syndrome of “railway spine” (Ericksen, 1867; 
Trimble, 1981) to describe the varying mixture of neurological damages, 
psychological arousal and conversion symptoms that originated after the many 
railway accidents of that time; in 1871, de Costa, an American army physician, 
described the syndrome of “irritable hearth” (De Costa, 1871; Paul, 1987), 
enhancing the role of cardiovascular symptoms in these reactions. Other 
diagnostic entities were later created, especially in the context of military 
settings, in order to define these presentations of post-traumatic syndromes in a 
culturally acceptable manner. Particularly, names such as “weakness of the 
heart”, “disordered action of the heart”, “valvular disease of the heart”, “trench 
syndrome”, “shell shock syndrome” and “combat fatigue” were reported 
(Skerrit, 1983; Paul, 1987).    
This concepts were later elaborated by authors at the turn between the 
XVIII and XIX century, but it is only at the end of the nineteenth century that 
Oppenheim first expressed the concept of psychic trauma, coining the word 
“traumatic neurosis”, in order to describe the anxiety states rising after the 
exposure to emotional trauma. Also Kraepelin, in his Psychiatric Treatise 
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(1896), included the description of the “Schreckneurose”, or “fright neurosis”, 
as an independent clinical disorder with a typical onset related to severe trauma 
such as railway accidents, fire, or any other kind of disaster.  
Nevertheless, it’s only with the World War I that the concept of 
traumatic neurosis, particularly as “war neurosis”, became a widely used term 
also outside the restricted group of experts. It’s in fact during the World War I 
that military physicians had to face an increasing number of soldiers presenting 
with this syndrome. Probably, the characteristics  of a long lasting trench 
warfare, with respect to the battles of the military tradition of the eighteenth 
century, played a relevant role. Just at the end of the World War I, in fact, Ernst 
Simmel (1918) published  the “Kriegsneurosen und psychisches Trauma” in 
which he fully treated the “war neurosis” syndrome suggesting a 
psychopathological onset of it. The observation of the inseparable presence of 
physical symptoms in psycho-traumatic disorders, performed during the World 
War I, led also Kadiner, an American army psychiatrist treating many veterans 
from World War I, to designate post-traumatic neurosis as a “physioneurosis” 
in 1941 (Kardiner, 1941).  
It’s important to notice that in military life, a notion of psychological 
distress was not acceptable in general until very recently. In the case of 
“traumatic neurosis” in fact, the negative connotation in the sense of secondary 
gain, in both the Anglo-Saxon and the German ambit, was exemplary in this 
respect. 
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 Anyway, after 1918, the interest recently arisen for these forms from 
the wide number of cases emerged to the attentions of military physicians, 
decreased rapidly for the natural decrease of the number of cases with the end 
of the war. This concept was then completely substituted with that of 
“reaction” (anxious or depressive) to traumatic or distressing events. It was 
only with the World War II that a new relevant number of cases was presented 
to the attention of clinicians.   
A decisive impulse towards an accurate characterization of these 
disorders and to the acceptance of  “post-traumatic stress disorder” as a formal 
diagnosis was given, with no doubt, in the United States by the effects of the 
Vietnam War and, in particular, by those post-traumatic syndromes that 
Vietnam veterans reported in the 60s and 80s. In those years, clinicians started 
to talk about a “post-Vietnam syndrome”, which clinical descriptions fully 
meet the criteria for modern PTSD.  
Despite the substantial evidences about the existence of a clinical 
syndrome developing as consequence of exposure to trauma of different kind 
and severity, no diagnostic category for disorders related to traumatic events 
was jet included neither in the Diagnostic and Statistical Manual of Mental 
Disorders (DSM), First Edition (APA, 1952) or Second Edition (APA, 1968). 
Only in 1980, with the third edition of the DSM, PTSD was fully included in 
the international psychiatric nomenclature, confirming the decisive role of 
Vientam war effects. 
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In DSM-III (APA, 1980), the term Post-Traumatic Stress Disorder was 
proposed by the American Psychiatric Association to describe, under a single 
definition, all the psychopathological syndromes typically developing after 
exposure to traumatic or distressing events that were “beyond the range of 
normal human experience”, and characterized by prolonged psychic distress. In 
this way, the American Psychiatric Association tried to give an unitary 
nosographic approach to the different post-traumatic syndromes previously 
described by different authors. 
From its first codification in the Diagnostic and Statistical Manual of 
Mental Disorders-IIIrd edition, in 1980, up to the latest DSM-IV-TR (APA, 
2000), the characteristics of either the provoking trauma and of the 
symptomatology have been progressively more accurately described and 
defined.  
One of the major evolutions has concerned the definition of the DSM 
Criterion A, that is the definition of the provoking trauma. While DSM-III 
defined trauma as an “event  beyond the range of normal human experience 
and that can induce stress symptoms in most of the people”, DSM-IV states as 
trauma “all the events that may threat one’s physical integrity and that can 
induce feelings of intense fear, helplessness or horror, and that could directly 
involve the patient, or that the patient cold witness or learn about”. This 
implies that the trauma is no more considered as an event outside the normal 
human experience, that is also a quite indefinite definition, but can include also 
very common experiences that can even happen in civilian population’s 
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everyday experience. Moreover, DSM-IV does not specify that the trauma has 
to be an event that may have induced a severe post-traumatic reaction in almost 
everybody exposed (DSM-III, 1980), reducing the relevance given to the 
severity of the trauma for the syndrome onset and highlighting the role of 
subjective vulnerability.  
In DSM-IV-TR (APA, 2000), no changes were reported to the criteria 
for PTSD diagnosis, in this latest version only un update of the associated 
features and of the comorbidity and familiarity were added. Although debate 
continues on whether an event could be defined as traumatic, that is able to 
elicit the onset of PTSD, the progressive evolution in the definition of the 
potentially traumatic events across DSM editions led to the actual definition 
(DSM-IV-TR, 2000) that includes either rare events (such as natural or human 
made disasters) and frighteningly common events (such as criminal 
victimization, rape or serious motor vehicle collision). 
With this definition of trauma in place, recent surveys on the general 
population have reported increasing rates in the lifetime prevalence of the 
disorder, that is now placed at approximately 10%. The Epidemiologic 
Catchment Area (Helzer et al., 1987), the first epidemiological study assessing 
PTSD in the general population according to DSM-III criteria, reported rates of 
0.9% (0.5% males and 1.3% females). More recently, adopting the DSM-IV 
criteria for PTSD, rates of 9.2% (6% males and 11.3% females) were reported 
in the Random Community Survey (Breslau et al., 1991), while rates of 7.8% 
(5.0% males e 10.4% females), in the National Comorbidity Survey (Kessler et 
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al., 1995). Interestingly all studies agree on the characteristic higher risk for 
females for developing the disorder. Females show rates of prevalence of 
PTSD that are almost twice as much as those reported by males, even when 
corrected for type of exposure (Prigerson et a, 2001). On the other hand, 
studies on trauma exposure constantly show the opposite, with males being 
exposed twice as much than females, further confirming females higher 
vulnerability to PTSD (Kessler et al., 1995). 
Despite the differences in prevalence rates, the occurrence of PTSD 
after severe psychological trauma provides the most persuasive evidence in 
favour of certain kinds of stress causing psychiatric illness. Nevertheless, it’s 
important to remind that event most severe psychological stressors can not to 
result in the  development of PTSD (or other forms of psychiatric illness), as it 
has been reported also for the terrorist attack to the Twin Towers on September 
11, 2001, were PTSD resulted in only approximately one out of ten residents of 
Manhattan, New York (Galea et al., 2005). These data stand as testimony to the 
resilience of the human psyche.  
 
 
Clinical Characteristics and Subthreshold PTSD 
 
Post-Traumatic Stress Disorder is a severe and often chronic disorder 
characterized by the development of symptoms in 3 domains, re-experiencing, 
avoidance and hyperarousal, that persist for at least a month according to 
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DSM-IV-TR (2000). As already mentioned current diagnostic criteria stipulate 
exposure to an event that threatens serious physical injury or death, and that is 
accompanied by feelings of intense fear, helplessness, or horror. The diagnosis 
then requires  
Traumatic events can be experienced directly by the patient or can be 
witnessed by the patient, such as an event that  threatens one’s death, injury, 
physical integrity, or can be learned about by the patient. DSM-IV-TR lists the 
traumatic events that could be experienced directly, including, even if they 
could be not limited to: military combat, violent personal assault (such as 
sexual assault, physical attack, robbery, mugging), being kidnapped, being 
taken in hostage, terrorist attack, torture, incarceration as a prisoner of war or 
in a concentration camp, natural or man made disasters, severe automobile 
accidents, or being diagnosed with life threatening illness. Witnessed events 
include, but are not limited to: observing the serious injury or the unnatural 
death of another person due to a violent assault, accident, war, or disaster or  
unexpectedly witnessing a dead body or body parts. The events experienced by 
others that are learned about include, even if they are not limited to: violent 
personal assault, serious accidents or serious injuries experienced by a family 
member or a close friend; learning about the sudden, unexpected death of a 
family member or of a close friend, or learning that one’s child has a life 
threatening disease. 
In accordance to DSM-IV-TR (Criterion A2), the person’s response to 
the trauma must involve intense fear, helplessness, or horror in order to be able 
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to determine a post-traumatic stress disorder. The way people respond during 
acute exposure to trauma is crucial in explaining whether they recover or 
develop mental health symptoms.  
DSM-IV-TR recognizes the existence of a different disorder than PTSD 
if the onset of the symptomatology lasts within the first month since the trauma 
has occurred: Acute Stress Disorder (ASD). As already reported PTSD can 
diagnosed only if symptoms last for at least one month. Acute Stress Disorder 
is denoted by the presence of prominent dissociative symptoms (e.g., 
derealization, numbing), and when it occurs after trauma, it usually identifies a 
subset of individuals who are at several fold increased risk for the subsequent 
development of PTSD (Bryant and Harvey 1998, Bryant, 2003). Nevertheless 
this time frame distinguishing between ASD and PTSD seems to be arbitrary 
and researcher are planning to reconsider the existence of ASD in the 
forthcoming DSM-V.  
DSM-IV-TR criteria for PTSD include the development of symptoms in 
3 domains, the first of whom is represented by reexperiencing. The traumatic 
event can be reexperienced in various ways. Commonly the person has 
recurrent intrusive recollections of the event, including images, thoughts or 
perceptions (Criterion B1 of the DSM-IV-TR, 2000) or recurrent distressing 
dreams during which the event is replayed (Criterion B2). In rare instances the 
person experiences dissociative states that last from a few seconds to several 
hours, or even days, during which components of the event are relieved and the 
person behaves as though experiencing the event at that moment (Criterion 
 25 
B3), this may include a sense of relieving the experience, illusions, 
hallucinations, and dissociative flashback episodes, including those that occur 
on awakening or when intoxicated. Intense psychological distress (Criterion 
B4) or physiological reactivity (Criterion B5) often occurs when the person is 
exposed to triggering events that resemble or symbolize an aspect of the 
traumatic event (e.g. anniversaries of the traumatic event; cold, snowy weather 
or uniformed guards for survivors of death camps in cold climates; hot, humid 
weather for combat veterans of the South Pacific; entering any elevator for a 
woman who was raped in an elevator). 
The second diagnostic domain for PTSD diagnosis in accordance to 
DSM-IV, includes avoidance and numbing symptoms. Stimuli associated with 
the trauma are, in fact, persistently avoided. The person commonly makes 
deliberate efforts to avoid thoughts, feeling or conversations about the 
traumatic event (Criterion C1) and to avoid activities, situations, or people who 
arouse recollections of it (Criterion C2). This avoidance of reminders may 
include amnesia for an important aspect of the traumatic event (Criterion C3). 
Diminished responsiveness to the external world, referred to as a “psychic 
numbing” or “emotional anaesthesia”, usually begins soon after the traumatic 
event. The individual may complain of having markedly diminished interest or 
participation in previously enjoyed activities (Criterion C4), of feeling 
detached or estranged from other people (Criterion C5), or of having markedly 
reduced ability to feel emotions (especially those associated with intimacy, 
tenderness, and sexuality) (Criterion C6). The individual may have a sense of a 
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foreshortened future(e.g. not expecting to have a career, marriage, children, or 
a normal life span) (Criterion 7).  
The third domain for PTSD diagnosis (DSM-IV-TR, 2000) includes the 
symptomatology related to increased arousal. The individual, in fact, usually 
reports persistent feeling of anxiety or increased arousal that were not present 
before the trauma. These symptoms may include difficulty falling or staying 
asleep that may be due to recurrent nightmares during which the traumatic 
event is relieved (Criterion D1), hypervigilance (Criterion D4), and 
exaggerated startle response (Criterion D5). Some individuals report irritability 
or outbursts of anger (Criterion D2) or difficulty concentrating or completing 
tasks (Criterion D3). 
The symptoms of PTSD usually occur soon after the occurrence of the 
traumatic event, although, in some cases, the symptoms develop months or 
even years after the trauma, in this case we talk about “PTSD with delayed 
onset”  (i.e., if symptoms onset at least 6 months after the trauma). The course 
of the disorder can be acute, if symptoms last less than 3 months, or chronic, 
they last over 3 months. In most cases the course is chronic, with the highest 
levels of symptomatology usually expressed within the first three months from 
the onset (Freedman et al., 1999; Shalev et al., 2000). 
Authors have reported how certain characteristics of the traumatic 
stressor or the immediate post-exposure response, including the magnitude of 
and proximity to the stressor (Engdahl et al., 1997;Breslau et al. 1999; 
Progerson et al, 2001), the occurrence of physical injury (Norris et al., 2000), 
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and the occurrence of peritraumatic dissociation (Fullerton et al., 2001; Bryant, 
2007), seem to increase the propensity to develop PTSD after exposure. 
However, individual differences also contribute to the variance in PTSD 
expression after trauma exposure, including female gender (Fullerton et al., 
2001; Bryant, 2007), genetic vulnerability (Stein et al., 2002), and a history of 
exposure to early childhood trauma (Breslau et al., 1999). This latter finding 
has been both particularly intriguing and exceptionally controversial. The 
controversy has been spurred, in part, by the methodological difficulties 
inherent in assessing the nature and severity of childhood trauma. Concerns 
range from the possibility that some individuals might recall being sexually 
victimized in childhood when this has not actually occurred (i.e., the so-called 
false memory syndrome) to the possibility that some traumatized individuals 
might have suppressed the memories of childhood victimization and, therefore, 
may be unable to report that they were, indeed,  traumatized. Nevertheless, a 
variety of studies suggest that early experiences of victimization predispose an 
individual to developing PTSD when later exposed to psychological trauma. 
On the cutting edge of traumatic stress research are recent studies that 
suggest that psychological trauma may result in quantifiable abnormalities in 
neurocognition (e.g., executive function) and perhaps, neuroanatomy (e.g., 
hippocampal volume). If replicated, these studies promise to dramatically alter 
understanding of the effects of stress on psychiatric disorders and, ultimately, 
on normal and pathological brain development. 
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Most recently, in line with the ongoing debate over the definition of the 
potentially traumatic event, investigators have emphasized the importance of 
determining whether the event is shocking to the individual or not, regardless 
of its form, in order to define it as traumatic, i.e. able to produce symptoms of 
traumatic stress (intrusion, numbing and arousal) (Galea et al., 2005). Although 
greater degrees of trauma are expected to yield higher rates of PTSD than less 
extreme traumas (Engdahl et al., 1997), increasing evidence documents the 
importance the so-called “low-magnitude” events (e.g., divorce, serious illness 
and financial reverses) in determining post-traumatic stress reactions (Breslau 
& Davis, 1987; Solomon & Canino, 1990, Moreau & Zisook, 2002). Davidson 
and Foa (1991) state ‘‘clinical observations seem to suggest that for some 
persons the loss of a job or marital separation may also give rise to this 
syndrome, leading to criteria B (re-experiencing), C (avoidance and numbing), 
and D (hyperarousal) symptoms of PTSD’’.  In the literature, two studies have 
assessed the impact of ‘‘low-magnitude’’ trauma, showing that events such as 
marital disruption, the death of a loved one, failed adoption plans, miscarriage, 
and poisoning may lead to PTSD (Burnstein, 1985; Heltzer et al., 1987). The 
nature of the stressor is believed to have considerable breadth, from the loss of 
a job or marital separation to the loss of a loved one or involvement in a serious 
accident or involvement in abuse or combat. 
On the other hand, several studies on post-traumatic conditions have 
recently emphasized the fact that significant functional impairment and seek 
for treatment is reported by a large number of victims who, even if exposed to 
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a DSM-IV-qualified trauma, did not fulfil the other criteria (B,C and D) for 
PTSD diagnosis (Stein et al.,1997; Marshall et al., 2001; Hepp et al., 2005). Sin 
line with these findings, some authors have introduced the concepts of partial, 
subthreshold or subsyndromal PTSD in order to better investigate the clinical 
relevance of these forms (Weiss et al., 1992; Carlier and Gersons, 1995; Stein 
et al.,1997).  
Marshall et al (2001) reviewed studies that demonstrated that 
subthreshold PTSD caused by various stressors was as common as full PTSD. 
In the National Vietnam Veterans Readjustment Study (Weiss et al., 1992), 
partial PTSD was defined by levels of dysfunction equivalent to PTSD, the 
presence of two of three symptom clusters, or meeting most criteria in each of 
the three clusters, and with this definition in place it was reported in 22.5% of 
men and 21.2% of women exposed to war-related trauma. In a longitudinal 
study of 132 persons involved in serious motor vehicle accidents, 28.5% met 
criteria for two symptom clusters 1 to 4 months after the accident (Blanchard et 
al., 1996). Carlier and Gersons (1995), in a study conducted on 136 survivors 
of a plane crash into two apartments, found that 20% of subject met criteria for 
two symptom clusters followed for 6 months. A community study that used 
standardized telephone interviews of 1002 persons asked about trauma, and 
positive replies were given a DSM-IV PTSD symptom checklist. Persons with 
partial PTSD had clinically meaningful levels of functional impairment in 
association with their symptoms (Stein et al., 1997). Impairment could not be 
directly attributed to PTSD symptoms in this sample, however, because there 
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was no control for comorbid conditions. Schutzwohl and Maercker (1999) 
compared 146 political prisoners in the former German Democratic Republic to 
subjects in that country who had not experienced trauma, of these 29% met 
criteria for partial PTSD, which was defined as satisfying criteria in the 
reexperiencing cluster and either hyperarousal or avoidance clusters. More 
recently, Marshall and collaborators (2001) found that 2608 of 9358 
individuals on National Anxiety Disorders Screening Day 1997 had at least one 
PTSD symptom for at least 1 month’s duration and impairment increased 
linearly with each increasing number of subthreshold PTSD symptoms. Even 
after controlling for the presence of major depressive disorder, individuals with 
subthreshold PTSD were at elevated risk for suicidal ideation. A limitation of 
this study includes the assessment of impairment by self-report and failure to 
assess for specific areas of impairment, such as occupational or social 
functioning. 
Most recently, results from a latent class analysis of two large 
epidemiological samples suggested the existence of a three-class structure 
separating trauma exposed persons with pervasive disturbance from those with 
intermediate or no disturbance (Breslau et al., 2005). 
 In line with these studies on partial and subthreshold forms, Moreau & 
Zisook (2002) developed a first multidimensional model approach to PTSD  
where these forms were included in a continuum encompassing from 
subsyndromal forms of stress-related disorders to full blown expressions, also 
assessing the spectrum of the nature of the potentially provoking events.  
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In accordance to Yehuda (1998), Moreau & Zisook (2002) also 
highlighted an important issue over partial forms suggesting that: subthreshold 
symptoms may represent a prodrome of the full syndrome or residual 
symptoms of PTSD in partial remission. Regarding the first possibility, a prof 
is given from the fact that individuals who react to trauma with dissociation are 
at elevated risk for later developing the full syndrome of PTSD (Yehuda, 
1998). For the second point, it’s important to notice that for many patients, 
mild symptoms, such as numbing of affect and irritability limited to the 
recollection of trauma, may persist indefinitely. Even after treatment, many 
individuals with PTSD continue to suffer from residual symptoms years after 
the full syndrome is no longer present (Marshall et al. 2001). Although 
empirical validation is needed, we can argue from clinical practice that 
individuals with residual symptoms may be more susceptible to developing the 
full syndrome after subsequent traumatic exposure than individuals with full 
symptom and functional recovery. Further, an important issue is determined by 
the characteristic course of PTSD, which is usually fluctuating in symptom 
severity, with persons meeting full criteria for diagnosis intermittingly over the 
course of many years (van der Kolk et al., 1996). 
Moreau & Zisook’s spectrum concept (2002) also considered the 
severity of PTSD spectrum designing it with: uncomplicated PTSD in the 
middle of the spectrum, and PTSD complicated with multiple comorbidities on 
the other side of the severity spectrum. More than 80% of patients with chronic 
PTSD, in fact, have at least one comorbid psychiatric condition, most often 
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mood, anxiety, or substance use disorders (Kessler et al., 1995). When 
comorbidity is present, PTSD is often misdiagnosed, chronic, more severe and 
impairing, and more difficult to treat (Yehuda, 1998).  
All these studies on subthreshold or partial forms of PTSD, and 
highlighting the ongoing issue of the definition of the trauma, have been 
determinant for the “Spectrum” concept developed by the researchers of the 
University of Pisa, within the international research collaboration project 
named “Spectrum Project”, for trauma and loss, that will be further presented 
in this thesis.  
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COMPLICATED GRIEF 
 
 
Life stressors usually entail exposure or confrontation with negative 
events that can often be represented by loss of positive events or situations. In 
PTSD diagnostic evolution across DSMs, there has been relevant point of 
interest in DSM-IV edition, represented by the fact that expanding the range of 
“qualifying” traumatic events (from the core category of traumas represented 
by military, combat and disaster and criminal violence), for the fist time also 
the death of a loved one from any cause, included natural causes, was included 
as a stressor (Breslau et al., 2001). DSM-IV, in fact, acknowledges the 
importance of life events that are life threatening by designating these as 
traumatic and loss is considered a trauma if it entails death that is “sudden” and 
“unexpected”.  
Although the revised concept of the "A" criterion has opened the door 
for bereavement, the epidemiologic studies on community samples that have 
been held in recent years to broaden the scope of stressful life events, have not 
considered "normal" bereavement to be the kind of event warranting a 
diagnosis of PTSD. Most published studies thus far, in fact, have excluded 
normal bereavement as an etiologic event for PTSD.  Not surprisingly, when 
the sudden unexpected death of a close friend or relative was included as 
“qualifying” event in epidemiological studies, it resulted to be the most 
common trauma found, with approximately 60% of men and women having 
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experienced an event of this type at some time in their lives. Further, the risk of 
PTSD associated with this trauma ranged around 16% in females and 13% in 
males (Breslau and Kessler, 1998).  
Authors are now debating whether other forms of death, for example, 
the death of a loved one who died from a chronic illness or whose death had 
been anticipated, may also lead to a PTSD-like syndrome and, if so, whether 
this syndrome is unique from other forms of PTSD. In other words, weather 
PTSD might, like depression (Zisook & Suchter, 1993) or other anxiety 
disorders (Jacobs et al., 1990) represent a possible adverse complication of 
bereavement. 
We can argue that if trauma has been described as entailing an event 
that violates strongly held beliefs about the security of the world and/or 
challenges the validity of existing mental models, the death of an attachment 
figure, even if not sudden and unexpected, would fully meet this criterion. 
Lindemann first outlined a broad spectrum of grief phenomena in 
survivors and family members of victims of the Coconut Grove Fire 
(Lindemann, 1944), and described five pathognomonic symptom complexes of 
this grief experience: 1) somatic distress accompanied by waves of intense 
discomfort, a sense of unreality, and numbing and avoidance; 2) preoccupation 
with images of the deceased; 3) guilt about surviving, or about what could or 
should have been done; 4) hostility; and 5) loss of ordinary patterns of conduct. 
Despite we have to notice a certain degree of overlap with PTSD 
symptomatology, probably due to the fact that the event that caused the deaths 
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most probably met DSM-IV criteria for trauma, Lindemann's observations 
legitimized the biomedical study of grief and bereavement and led to a 
considerable number of empirical investigations of grief phenomena, course, 
and complications. Nevertheless, despite Lindemann's emphasis on stress-like 
experiences among the bereaved, most subsequent studies have emphasized the 
depressogenic aspects of bereavement (Gallagher et al., 1983; Jacobs et al., 
1989; Zisook and Suchter, 1993), and relatively less attention has been devoted 
to looking at bereavement as a serious stressor, capable of resulting in a 
"traumatic stress disorder." 
Some authors that have examined grief as a general stressor exploring 
the characteristics of the loss: Parkes (1990), for example, noted the increased 
life disruption, stress-like phenomena, and chronicity of bereavement when the 
death was sudden and unanticipated as opposed to insidious or expected, 
defining the "unexpected loss syndrome" as one of the pathologic forms of 
grief (Parkes, 1983). Lundin described unanticipated loss as associated with 
increased psychiatric morbidity, anxiety, grief reactions, and functional 
incapacity compared with grief following expected deaths (Lundin, 1987). 
Describing grief after homicide or suicide, Rynearson emphasized the 
traumatic aspects of the loss by describing ongoing themes of violation, 
victimization, and volition, and underscores the primacy of PTSD phenomena 
over grief phenomena in non-recovery (Rynearson, 1986).  
More recently, authors have progressively investigated the correlations 
between PTSD and bereavement. Some of the few investigators to actually 
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describe the prevalence of PTSD after the death of a loved one, Schut and 
collaborators (1991) found rates from 20-31% over the first 2-years of spousal 
bereavement and that 9% met PTSD criteria at every stage throughout the 2 
year data collection period (Schut et al., 1991). Zisook and collaborators (1998) 
examined the prevalence, course, comorbidity, and consequences of PTSD 
after spousal bereavement finding that that at 2 months after the spouse's death, 
criteria for PTSD were met by 10% of those whose spouses died after a chronic 
illness, by 9% of those whose spouses died unexpectedly, and by 36% of those 
whose spouses died from "unnatural" causes (suicide or accident) had PTSD. 
Moreover, symptoms tended to be chronic in at least 40% of the subjects, 
almost always were associated with comorbid depression and created 
substantial morbidity. Authors concluded that PTSD may occur after 
bereavement suggesting that the 'A' criterion of the official diagnostic system 
(DSM-IV) would need further examination. 
In line with these concepts, more recently some authors have identified 
a syndrome of pathological response to bereavement, called “Traumatic” or 
“Complicated Grief” (CG), as a form of stress response (Prigerson et al., 1995, 
1999; Horowitz et al 1997; Shear & Smith-Caroff, 2002; Langner & Maercker, 
2005; Shear & Shair, 2005). Prigerson and collaborators (1996, 1997) first 
identified this syndrome as distinct from either bereavement-related depression 
or anxiety, and defined it as characterized by intense and prolonged 
preoccupation with thoughts of the deceased, yearning and searching 
behaviours, disbelief, and avoidance. Similarly to PTSD, only a subset of 
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people who experience a loss may develop a pathological response to 
bereavement such as CG (Horowitz et al, 1997; Maercker et al., 1998). This 
form of response to bereavement might also share features of response to a 
DSM-IV traumatic event, such as a sense of disorientation and confusion, and a 
tendency to intrusive thoughts oscillating with avoidance (Horowitz et al, 
1997; Maercker et al., 1998), and entails separation distress with intense 
yearning, searching and longing for the person who died, and preoccupation 
with thoughts and memories of the deceased (Shear et al., 2005). 
In line with these considerations, when looking at the spectrum of 
possible triggering events, while developing the Trauma and Loss Spectrum 
concept, both life threatening situations and bereavement were considered as 
potential triggers for a trauma response. Moreover, the way how either of these 
might be associated with long term clinically significant symptoms was 
explored. 
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3. THE TRAUMA AND  LOSS  SPECTRUM  
(SCI-TALS) 
 
 
The Trauma and Loss Spectrum Concept 
 
Clinicians and researchers are increasingly interested in better 
characterization of psychiatric disorders than that provided in DSM IV-TR 
(Kupfer, 2005; Maj, 2005; Maser & Akiskal 2002).  
Current categorical methods of classification of mental disorders, such 
as the Research Diagnostic Criteria (RDC) (Spitzer et al., 1978), the Diagnostic 
and Statistical Manual of Mental Disorders 4th edition (APA, 1994) and the 
International Classification of Diseases 10th edition (ICD-10), have provided a 
reliable tool for epidemiologic, clinical and, especially, treatment outcome 
research. Nevertheless, despite adding specificity to the psychiatric 
nomenclature, their stereotypic rigidity in classification, the so-called 
“threshold psychiatry”, has failed in identifying the full range of subthreshold, 
atypical and often enduring symptoms that encompass the core manifestations 
of full-blown mental disorders, thus leading to the misdiagnosis of atypical 
disorders. In fact, patients suffering from subsyndromal forms of axis I 
disorders, either alone or in comorbidity with other full-blow axis I disorders, 
cannot be easily accommodated within these rigidly structured nosological 
systems (Frank et al., 1998; Cassano et al., 1999). Despite this, these often 
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neglected spectra of symptoms may be as distressing and debilitating as the 
full-blown disorder and have unrecognized importance in seek for treatment 
(Galea et al., 2003). Recently, lifetime spectrum symptoms of a range of mood 
and anxiety disorders were also found to contribute to impairment (Bazzichi et 
al., 2005; Fagiolini et al., 2005), to represent a risk factor for suicidality 
(Balestrieri et al., 2006), and to influence treatment outcome (Frank et al., 
2000; Frank et al., 2002; Dell’Osso et al., 2007). Furthermore, increasing 
evidence has been reported for a lack of correspondence between current 
classifications of mental disorders and psychopathological presentations, in 
both community and clinical settings and this has often led to an incomplete 
characterization of most patients (Cassano et al., 1999).  
For what is concerned to PTSD, the relevance of these partial or 
subsyndromal forms, besides the importance of a multidimensional approach to 
this particular disorder typically related to a provoking event, has been already 
widely exposed in a previous sessions of the present thesis (see Clinical 
characteristics and subthreshold PTSD). Nevertheless, most recent data 
confirming these considerations derive from studies on the psychological 
sequelae and seek for treatment risen in Manhattan and New York residents, 
after the September 11- 2001 terrorist attack (Galea et al., 2003, Galea et al., 
2005; Agronic et al., 2007).  
Surely, the correct identification and recognition of these atypical and 
subsyndromal expression of psychopathology may lead to improved clinical 
characterization and more effective treatment for most patients. Probably, this 
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approach is required also to fill the gap that is present between the actual 
psycho-pathological expression of psychiatric disorders and the current 
diagnostic categories, in line with the perspectives of including dimensional 
approaches in the new edition of DSM-V.  
 Neurobiological studies also corroborate this hypothesis, suggesting 
the need for a better characterization of clinical phenotypes that may help, in a 
more efficacious way, understanding the patophysiology of psychiatric 
disorders.  
In line with these considerations, researchers have worked towards a re-
conceptualization and assessment of the spectrum phenomena, identifying 
these phenomena as mosaics comprising recognizable and treatable 
manifestations of the full-blown disorder. This has already led to the concepts 
of schizophrenia (Kety et al., 1968), bipolar (Akiskal, 1983), and obsessive-
compulsive (Hollander, 1993) spectrums, although different authors have 
defined different meanings of the term “spectrum”.  
The need for a systematic identification and assessment of a broad array 
of symptoms and behavioural features related to Axis I disorders has induced a 
group of researchers from the Institute of Psychiatry at the Department of 
Psychiatry, Neurobiology, Pharmacology and Biotechnologies, of the 
University of Pisa (Italy), led by Prof. G.B. Cassano, to the conceptualization 
of a new “spectrum” model. With the term “spectrum” these authors (Cassano 
et al., 1997), include the core symptoms of current DSM diagnostic categories, 
not limiting to them but also referring to broad areas of psychiatric 
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phenomenology relating to a given axis I disorder including: (1) core, atypical, 
and subclinical symptoms of DSM's axis I disorder; (2) signs, isolated 
symptoms, symptoms clusters and behavioural patterns related to the core 
symptoms and (3) clinical features which have ordinarily been viewed as 
temperamental and/or personality traits. 
This model has been developed within an international research 
collaborative group, named “the Spectrum Project”, started in 1995 and is still 
ongoing, between researchers of the Psychiatric Clinic of the University of Pisa 
and researchers of the Western Psychiatric Institute and Clinic at the University 
of Pittsburgh, the University of California San Diego, and from the Columbia 
University of New York. This Project is aimed at the definition and assessment 
of the subthreshold and atypical phenomenology encompassing mental 
disorders. It first applied to panic agoraphobic (Cassano et al., 1999) and mood 
spectra (Dell’Osso et al., 2002; Cassano et al., 2004), it has been constructed 
by identifying different psychopathological symptoms and grouping them into 
clinical domains that comprise the conceptual organization incorporating and 
extending the Axis I disorders as described in DSM-IV.  
Based on the same theoretical foundation, specific diagnostic 
instruments, developed to assess a broad array of clinical features associated 
with different DSM conditions, have been developed and tested within this 
Project.  These “spectrum” instruments comprise a set of structured clinical 
interviews and self report questionnaires, that evaluate isolated criterion and 
non-criterion symptoms, behavioural tendencies and temperament-like traits 
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experienced over a lifetime, for most of the DSM-IV disorders (Fagiolini et al., 
1999; Cassano et al., 1999; Mauri et al., 2000; Dell’Osso et al., 2000; 
Dell’Osso et al., 2002a, 2002b; Sbrana et al., 2003; Sbrana et al., 2005). 
The latest of these spectrum assessment instruments is represented by 
the Structured Clinical Interview for Trauma and Loss Spectrum (SCI-TALS), 
that targets PTSD and CG, which validity is being evaluated in the study 
reported in the present thesis.  
This trauma spectrum is based on the premise that PTSD symptoms are 
on a continuum with normal reactions to trauma exposure rather than being 
qualitatively different (Moreau & Zisook., 2002; Shear et al., 2002). This 
consideration is in line with the recent literature on subthreshold PTSD that 
have begun to demonstrate comparable impairment in individuals who 
experienced only some, but not all, symptoms of PTSD (Weiss et al., 1992; 
Carlier & Gersons, 1995; Stein et al., 1997; Schurzwohl & Maerker, 1999; 
Marshall et al., 2001; Ruscio et al., 2002; Hepp et al., 2005).  
Nevertheless, PTSD requires a dual process of trauma exposure and 
response and recent dimensional approach to PTSD have highlighted the need 
for a multidimensional model (Moreau & Zisook, 2002; Breslau 2005). What 
constitutes trauma was hotly debated in the development of the DSM criteria 
since PTSD is unique in the DSM, as a disorder specifically tied to a life event. 
The conservative position that trauma requires exposure to an event that is 
threatening to physical integrity is sensible from many standpoints, but it is 
likely inaccurate with respect to the development of clinically significant 
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symptoms since this pattern of symptoms can be seen in response to other 
events (e.g., a lawsuit) (Shear, 2002). Thus, it is possible that a clinically 
significant condition may be produced by subthreshold trauma exposure 
(Breslau & Davis, 1987; Solomon & Canino, 1990; Moreau & Zisook, 2002) 
associated with threshold or subthreshold symptoms.  If an important evolution 
in the diagnostic criteria for PTSD, has concerned the inclusion of the victim’s 
appraisal of the event, recent literature emphasize how, for some persons, even 
“minor” events such as the loss of a job or marital separation, may also give 
rise to PTSD (Burnstein, 1985; Heltzer et al., 1987; Zisook et al., 1998; 
Pfefferbaum et al., 2000). 
Given the requirements of DSM-IV-TR (2000) for PTSD diagnosis, 
that is the need for a threshold level of exposure and for criterion level 
symptoms, and in line with the literature addressing the role of subthreshold 
trauma and subthreshold PTSD, when developing a spectrum assessment of 
this condition (SCI-TALS), we included a continuum of potentially triggering 
events and a range of symptoms that comprise an acute reaction, and an array 
of persistent symptoms.  
To provide a spectrum assessment for PTSD, we first created a list of 
possible triggering events where we included low magnitude, subthreshold 
events  (e.g., divorce, serious illness and financial reverses) capable of 
producing clinically significant symptoms related to PTSD, in accordance to 
recent literature (Breslau & Davis, 1987; Solomon & Canino, 1990; Moreau & 
Zisook, 2002; Hepp et al., 2005). Moreover, we included loss events as highly 
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stressful experiences capable of evoking a specific constellation of grief 
symptoms, in line with recent work identifying a syndrome of complicated 
grief as a form of stress response (Prigerson et al., 1995; Horowitz et al 1997; 
Prigerson et al., 1999; Shear & Smith-Caroff, 2002; Langner & Maercker, 
2005; Shear & Shair, 2005).  In line with these studies, when developing a 
spectrum assessment for post-traumatic conditions, we decided to consider 
both life threatening situations and bereavement as potential triggers for a 
trauma response, and we considered how either of these might be associated 
with long term clinically significant symptoms. We considered that stressful 
life events can be broadly categorized as those that entail exposure to a 
threatening negative life event and those that entail loss of an important 
positive relationship or situation, not limiting the loss events only to death.  
The SCI-TALS includes 116 items coded in a dichotomous way (yes/no 
answer) divided into IX domains. The spectrum of losses and potentially 
traumatic events are investigated into two different domains (I and III 
respectively).  
In order to accommodate the different symptomatological 
manifestations that can be related to post-traumatic stress syndromes, we 
postulated a post-traumatic spectrum model to capture the continuum between 
the core symptoms of Axis I disorders and the associated prodromal, atypical 
and sub-clinical psycho-pathological expressions (Cassano et al., 1997). A first 
symptomatological domain was created in the SCI-TALS in order to assess 
acute reaction to either trauma and loss (Domain IV). Further, domains 
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assessing the spectrum of symptoms related to re-experiencing (Domain V), 
avoidance and numbing (Domain VI), and arousal (Domain VIII) were created. 
In order to allow a more accurate detection of grief responses a separate 
domain assessing these symptoms was added  (Domain II). Two adjunctive 
domains were included: one assessing maladaptive coping (Domain VII) that 
may emerge since the trauma or the loss had happened; and one assessing 
personal characteristics or risk factors (Domain IX) that may account for post-
traumatic symptoms onset. 
In conclusion, the nine domains of the trauma and loss spectrum 
incorporate the typical symptomatology of Post-Traumatic Stress Disorder 
(PTSD) and complicated grief (CG), together with the array of subthreshold 
and atypical post-traumatic and grief symptoms which are less frequently 
linked to PTSD and CG. What follows is a systematic description of each 
domain of the Trauma and Loss Spectrum (SCI-TALS) from a 
psychopathological and clinical standpoint.  
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The SCI-TALS instrument 
 
The SCI-TALS was developed by the international team of researchers 
belonging to the “Spectrum Project”. Originally developed in English, the 
interview was then translated into Italian and then back translated into English 
in order to revise for inconsistencies between the two languages. In the 
validation study reported in the present thesis, the revised Italian version was 
utilised.   
The SCI-TALS includes 116 items exploring lifetime traumatic events 
or losses and lifetime symptoms, behaviours and personal characteristics that 
might represent risk factors for the development of the disorder. The 
instrument is organized into 9 domains. Items responses are coded in a 
dichotomous way (yes/no) and domain scores are obtained by counting the 
number of positive answers. 
 
Domain I: Loss Events (Items 1-10) 
Life stressors usually entail exposure or confrontation with negative 
events that can often be represented by loss of positive events or situations. 
When developing a spectrum assessment for post-traumatic stress, both life 
threatening situations and bereavement were considered as potential triggers 
for a trauma response. In order to better distinguish bereavement and life 
threatening situations as potential triggers for a trauma response, and to 
consider how either of these might be associated with long term clinically 
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significant symptoms, two different domains of the SCI-TALS were created, 
Domain I and III respectively.  
DSM-IV acknowledges the importance of life events that are life 
threatening by designating these as traumatic and loss is considered a trauma if 
it entails death that is sudden and unexpected. Nevertheless, trauma has also 
been described as entailing an event that violates strongly held beliefs about the 
security of the world and/or challenges the validity of existing mental models, 
and the death of an attachment figure, even if not sudden and unexpected, fully 
meets these criterion. 
Even if the revised concept of criterion “A” in DSM-IV, with respect to 
DSM-III-R,  opened the door for bereavement, not many epidemiological 
studies have considered “normal” bereavement to be the kind of event 
warranting a diagnosis of PTSD (Zisook et al., 1998). However, this 
convention is somewhat arbitrary and may not be consistent with emerging 
information. The first epidemiologic study using DSM-IV criteria for the 
“bereavement” stressor found high rates of PTSD in civilian populations, 
where it was previously considered relatively rare, especially when the sudden 
and unexpected death of a loved one was counted as a traumatic event (Breslau 
et al., 1998). Schut and collaborators (1991) first described the prevalence of 
PTSD after the death of a loved one, that was “normal bereavement”, finding 
rates from 20-31% over the first two-years of spousal bereavement, with 9% 
meeting PTSD criteria at every stage throughout the 2-year data collection 
period. More recently, Zisook and collaborators (1998), examining the 
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prevalence, course comorbidity and consequences of PTSD after spousal 
bereavement, found even higher rates of the disorder, that is in: 10% of those 
whose spouse died after chronic illness, 9% of those whose spouses died 
unexpectedly, and in 36% of those who spouses died from “unnatural causes”. 
Moreover, symptoms tended to be chronic in at least 40% of the subjects and 
almost always were associated with comorbid depression, and created 
substantial morbidity.  
Besides considering the relevance of “normal” versus “sudden and 
unexpected” death in determining post-traumatic symptomatology, recently 
authors are debating that stressful life events can be broadly categorized as 
those that entail exposure also to loss of an important positive relationship or 
situation. In this concept, while developing the SCI-TALS, we wanted to apply 
the spectrum concept to loss events considering not only people’s death but 
broadening the scope of stressful losses, that might count for the “A” criterion. 
For this reason this domain encounters a number of items referring to possible 
losses either related to the sudden and unexpected death of relatives or close 
friends, as it is encountered in DSM-IV criterion A for PTSD, or to normal 
bereavement, or either to the loss of relationships and/or events that may have 
been relevant for the patient. 
 
Domain II: Grief Reactions Loss Events (Items 11-32) 
A syndrome of pathological response to bereavement, named 
complicated or traumatic grief, has been recently defined (Prigerson et al., 
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1995; Horowitz et al 1997; Shear and Shair, 2005). This grief response, that 
can develop after losses that may also not be as traumatic as it’s required in 
DSM-IV criterion A for PTSD, has been identified as a form of stress response 
(Prigerson et al., 1995; Horowitz et al 1997; Prigerson et al., 1999; Shear & 
Smith-Caroff, 2002; Langner & Maercker, 2005; Shear & Shair, 2005). 
Similarly to what happens in PTSD, this pathological response to bereavement 
can be reported by only a subset of people who experience a loss (Horowitz et 
al, 1997; Maercker et al., 1998; Prigerson et al., 1995a), enhancing the 
relevance of the subjective traumatic response to a loss event.  
Prigerson and collaborators (1997) identified the syndrome of 
Complicated Grief, distinct from either bereavement-related depression or 
anxiety, and described it as characterized by intense and prolonged 
preoccupation with thoughts of the deceased, yearning and searching 
behaviours, disbelief, and avoidance (Prigerson et al 1996, 1997). This 
pathological reaction to bereavement might also share features of response to a 
DSM-IV traumatic event, such as a sense of disorientation and confusion, and a 
tendency to intrusive thoughts oscillating with avoidance (Horowitz et al, 
1997; Maercker et al., 1998). Entailed symptoms of separation distress are 
represented by intense yearning, searching and longing for the person who 
died, and preoccupation with thoughts and memories of the deceased (Shear et 
al., 2005). 
In order to allow an accurate detection of grief responses Domain II has 
been developed. 
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Domain III: Potentially Traumatic Events (Items 33-58) 
The essential feature of Post-Traumatic Stress Disorder is the 
development of characteristics symptoms of exposure following to an extreme 
traumatic stressor involving direct personal experience of an event that 
involves actual or threatened death or serious injury, or other threat to one’s 
physical integrity; or witnessing an event that involves death, injury, or a treat 
to the physical integrity of another person; or learning about unexpected or 
violent death, serious harm, or threat of death, or injury experienced by a 
family member or other close associates (DSM-IV-TR Criterion A, 2000).  
As previously introduced, Domain III is the second domain assessing 
the lifetime potential trauma experienced by the patient and particularly, it 
explores the lifetime presence of exposure to a broaden spectrum of potentially 
traumatic events than that presented in DSM-IV. 
Although PTSD was not long ago considered to be a disorder of war 
veterans, it is now recognized as a highly prevalent disorder, affecting a much 
larger segment of the population, and this is mostly related to the progressive 
characterization of the potentially traumatic events. The definition of the 
criteria for the traumatic event has in fact evolved across the different DSM 
editions: while current diagnostic criteria (DSM-IV-TR, 2000) stipulate 
exposure to an event that threatens serious physical injury or death, and that is 
accompanied by feelings of intense fear, helplessness, or horror, DSM-III 
(1980) initially described trauma in relation to the degree of emotional impact 
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caused by an event that was “beyond the range of normal human experience”. 
Consequently, although debate continues, it is now generally accepted that any 
life-threatening (or, perhaps, life-altering) event, however common (e.g., a 
serious motor vehicle collision), can be considered sufficiently traumatic, that 
it is capable of eliciting PTSD. With this definition in place, recent surveys 
have placed the lifetime prevalence of PTSD in the community at 
approximately 10%.  
DSM-IV-TR lists the traumatic events that could be experienced 
directly, including, even if they could be not limited to: military combat, 
violent personal assault (such as sexual assault, physical attack, robbery, 
mugging), being kidnapped, being taken in hostage, terrorist attack, torture, 
incarceration as a prisoner of war or in a concentration camp, natural or man 
made disasters, severe automobile accidents, or being diagnosed with life 
threatening illness. Witnessed events include, but are not limited to: observing 
the serious injury or the unnatural death of another person due to a violent 
assault, accident, war, or disaster or  unexpectedly witnessing a dead body or 
body parts. The events experienced by others that are learned about include, 
even if they are not limited to: violent personal assault, serious accident or 
serious injuries experienced by a family member or a close friend; learning 
about the sudden, unexpected death of a family member or of a close friend, or 
learning that one’s child has a life threatening disease. 
Investigators continue to consider how best to define the range of 
events that might evoke clinically significant symptoms. Recently, the 
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importance of determining whether the event is shocking to the individual or 
not, regardless of its form, has been emphasized in order to define it as 
traumatic, i.e. able to produce symptoms of traumatic stress (intrusion, 
numbing and arousal) (Galea et al., 2005). In fact, increasing evidence 
documents the importance the so-called “low-magnitude” events, such as 
divorce, serious illness and financial reverses, in determining post-traumatic 
stress reactions (Breslau & Davis, 1987; Solomon & Canino, 1990, Moreau & 
Zisook, 2002).  
In line with these studies, in devising the SCI-TALS we included low 
magnitude, subthreshold events besides Axis I traumas as those assessed in the 
SCID Criterion A for PTSD diagnosis (DSM-IV) and listed before, except for 
the losses that, as already mentioned, are listed in Domain I.  
 
Domain IV: Reaction to Losses or Upsetting Events (Items -59-76) 
This domain includes the spectrum of the peritraumatic 
symptomatological response that the subject may experience during exposure. 
In accordance to DSM-IV-TR (Criterion A2), the person’s response to the 
trauma must involve intense fear, helplessness, or horror in order to be able to 
determine a post-traumatic stress disorder. Nevertheless, only a small 
percentage of subjects exposed to a same stressor (almost 1 out of 10) develop 
PTSD, confirming the resilience of the human psyche. Risk factors that may 
increase the propensity to develop PTSD after exposure, have been long 
investigated but authors agree on confirming only few of them, such as: gender 
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(Breslau et al., 1991; Kessler et al., 1995; Fullerton et al., 1999; Bryant et al., 
2003), certain characteristics of the trauma and the magnitude of and proximity 
to the stressor (Breslau et al., 1999; Prigerson et al., 2000),  the occurrence of 
physical injury (Norris et al., 2000), and the immediate post-exposure response 
including, in particular, the occurrence of peritraumatic dissociation (Fullerton 
et al., 2001; Punamaki et al., 2005), with this latest representing one of the 
most relevant.  
The way people respond during acute exposure to trauma is crucial in 
explaining whether they recover or develop mental health symptoms. It is 
generally agreed that showing dissociation, i.e., losing sense of time, behaving 
mechanically (“like a machine”), or feeling like a bystander watching events 
occur is a risk for PTSD. Shalev and his team (Shalev et al., 1997; Shalev et 
al., 1998; Freedman et al., 1999) confirmed, in their prospective studies, that 
peritraumatic dissociation predicts PTSD among accident victims. Positive 
associations between peritraumatic dissociation and PTSD have also been 
found in retrospective study settings among war veterans (Bremner et al., 1993; 
Marmar et al., 1994; O’Toole et al., 1999; Tichenor et al., 1996), disaster and 
accident survivors (Holen et al., 1993; Koopman et al., 1994; Ursano et al., 
1999), and emergency workers (Weiss et al., 1995).  
Moreover, recent studies highlighted that in more than 90% of the 
cases, patients also experience symptoms of anxiety and increased arousal at 
the time of exposure (Dunner, 2001) that can be experienced in higher or lesser 
degree, such as pounding heart, sweating, trembling, or shaking sensations of 
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shortness of breath or choking, chest discomfort or pain, nausea or abdominal 
distress, feeling dizzy, unsteady, light-headed, or faint. Shalev and 
collaborators (1998) reported early signs of neurophysyological activation as 
predictors of PTSD: heart rate in the per-traumatic phase, i.e. in the emergency 
room after traffic accidents, etc., was also positively correlated to the 
development of PTSD. In an extension of the study, again peritraumatic 
dissociation and heart rate predicted the development of PTSD and were 
associated with more intrusive symptoms and with exaggerated startle (Shalev 
et al., 1998). 
In the actual nosography (DSM-IV-TR, 2000), whether a defined 
cluster of symptoms appear in the immediate aftermath of the trauma or it 
develops and lasts within a month form it, a diagnosis of Acute Stress Disorder 
(ASD) can be formulated. This disorder, which development typically occurs 
within a month after exposure to an extreme traumatic stressor (DSM-IV-TR, 
2000), is denoted by the presence of characteristic anxiety and prominent 
dissociative symptoms (e.g. derealization, numbing) that can develop since the 
immediate aftermath of the trauma experience (DSM-IV-TR, 2000). Studies 
show that when acute stress disorder occurs after trauma, it identifies a subset 
of individuals who are at several fold increased risk for the subsequent 
development of PTSD (and major depression). 
Nevertheless, new perspectives in the view of DSM-V definition 
highlight the artificial temporal delimitation that delineates ASD from PTSD 
suggesting its elimination.  
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In line with these recent concepts, while developing the SCI-TALS no 
domain for ASD assessment was developed. Domain IV includes a broaden 
spectrum of peritraumatic/acute reactions to the trauma that encompass from 
the symptoms of intense fear, helplessness, or horror defined in  DSM-IV-TR 
Criterion A2 to the symptoms of increased anxiety and dissociative symptoms 
that characterize PTSD. Moreover, this Domain includes those symptoms that 
DSM-IV-TR describes as possible associated descriptive features of ASD. 
These are represented by symptoms of despair and hopelessness, besides 
feelings of guilt that the patient may experience if the trauma led to another’s 
death or to serious injury. Survivors in fact, may feel guilty about having 
remained intact or about not providing enough help to others (DSM-IV-TR, 
2000)  
 
Domain V: Re-experiencing (Items 77-85) 
The SCI-TALS is aimed at bringing to light not only the spectrum of 
the acute reactions (Domain IV) to potentially traumatic events, but also the 
persistent symptoms that may ensue from either type of life event (Domain V, 
VI, VIII). 
The diagnosis of PTSD requires development of symptoms in 3 
domains, re-experiencing, avoidance and hyperarousal, that persist for at least a 
month (DSM-IV-TR, 2000). Nevertheless, several studies on post-traumatic 
conditions, recently reported significant functional impairment and seek for 
treatment in a large number of victims who, even if exposed to a DSM-IV-
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qualified trauma, did not fulfil the other criteria (B,C, and D) for PTSD (Stein 
et al.,1997; Marshall et al., 2001; Hepp et al., 2005). Other authors (Weiss et 
al., 1992; Carlier & Gersons, 1995; Stein et al.,1997) have introduced the 
concepts of partial, subthreshold or subsyndromal PTSD in order to better 
investigate the clinical relevance of these forms. Results from a latent class 
analysis of two large epidemiological samples suggest the existence of a three-
class structure separating trauma exposed persons with pervasive disturbance 
from those with intermediate or no disturbance (Breslau et al., 2005).  
The traumatic event can be reexperienced in various ways. Commonly 
the person has recurrent intrusive recollections of the event, including images, 
thoughts or perceptions (DSM-IV-TR Criterion B1, 2000) or recurrent 
distressing dreams during which the event is replayed (Criterion B2). In rare 
instances the person experiences dissociative states that last from a few 
seconds to several hours, or even days, during which components of the event 
are relieved and the person behaves as though experiencing the event at that 
moment (Criterion B3), this may include a sense of relieving the experience, 
illusions, hallucinations, and dissociative flashback episodes, including those 
that occur on awakening or when intoxicated. Intense psychological distress 
(Criterion B4) or physiological reactivity (Criterion B5) often occurs when the 
person is exposed to triggering events that resemble or symbolize an aspect of 
the traumatic event (e.g. anniversaries of the traumatic event; cold, snowy 
weather or uniformed guards for survivors of death camps in cold climates; 
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hot, humid weather for combat veterans of the South Pacific; entering any 
elevator for a woman who was raped in an elevator). 
The whole list of “typical” symptoms reported in DSM-IV-TR criteria 
for PTSD has been reported in the SCI-TALS, making it possible to assess the 
full blown symptomatology of reexperiencing. Nevertheless, the clinical 
evidence that patients presenting with post traumatic symptoms characterized 
by fewer than the symptoms required from DSM-IV-TR may show a 
substantial impairment, similar to that of full PTSD (Stein et al.,1997; Marshall 
et al., 2001), prompted us to focus on detecting such phenomena 
systematically. Moreover, clinical evidence suggests that subthreshold and 
“atypical” symptoms are common in PTSD patients. These subclinical but 
distressing symptoms may sometime represent the only clinical manifestation 
of PTSD (Galea et al., 2005). It is not clear weather they are self limited or 
prodromal to a future occurrence or residual symptoms of full-blown PTSD. 
Although not listed among DSM-IV-TR criteria for PTSD, such symptoms 
may be experienced as a deep feelings of guilt, shame or blame, whose severity 
is comparable to that of a full-fledged PTSD; or sometimes they must be 
related to different behaviours that close friends or relatives tend to have in 
order to avoid patients sufferance (such as avoiding to talk about the event or 
the loss in order to avoid the patient to get upset). To a large extent, they tend 
to worsen and/or prolong reexperiencing, augmented arousal and avoidant 
symptomatology, opening the way to permanent, chronic changes in the 
emotional life and behaviour of the patients. DSM-IV-TR considers among the 
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associated descriptive features the possibility that patients with PTSD may 
describe painful guilt feelings about surviving, or feelings of ineffectiveness, 
shame and despair. 
In the long run these often neglected subthreshold and atypical 
symptoms may become the major determinants of changes in personality, 
leading to a deceptive diagnosis of a personality disorder.  
For these reasons “atypical” symptoms were included as a section of 
either the reexperiencing, avoidance and numbing and arousal domains, along 
with the “typical” ones reported in DSM-IV-TR. 
 
Domain VI: Avoidance and numbing (Items 86-97) 
As already mentioned, symptoms of avoidance and numbing represent 
one of the three symptoms clusters that constitute PTSD (DSM-IV-TR, 2000). 
Stimuli associated with the trauma are, in fact, persistently avoided. The person 
commonly makes deliberate efforts to avoid thoughts, feeling or conversations 
about the traumatic event (DSM-IV-TR Criterion C1, 2000) and to avoid 
activities, situations, or people who arouse recollections of it (Criterion C2). 
This avoidance of reminders may include amnesia for an important aspect of 
the traumatic event (Criterion C3). Diminished responsiveness to the external 
world, referred to as a “psychic numbing” or “emotional anaesthesia”, usually 
begins soon after the traumatic event. The individual may complain of having 
markedly diminished interest or participation in previously enjoyed activities 
(Criterion C4), of feeling detached or estranged from other people (Criterion 
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C5), or of having markedly reduced ability to feel emotions (especially those 
associated with intimacy, tenderness, and sexuality) (Criterion C6). The 
individual may have a sense of a foreshortened future (e.g. not expecting to 
have a career, marriage, children, or a normal life span) (Criterion C7)  
The whole list of “typical” symptoms reported in DSM-IV-TR criteria 
for PTSD has been reported in the SCI-TALS, making it possible to assess the 
full blown symptomatology of avoidance and numbing. Nevertheless, in line 
with the concepts applied for reexperiencing, while creating the spectrum of 
avoidance and numbing symptomatology subthreshold and “atypical” 
symptoms were taken into account. Symptoms such as those reported in the 
DSM-IV-TR associated features of PTSD were enlisted as “atypical” features, 
such as: feeling permanently damaged (Item 96. Did you ever feel as if your 
life was changed forever and things would never be the same?); impaired 
relationships with others (Item 94. Did you ever have difficulty trusting people, 
either strangers, people in your family, or your friends?); or a change from the 
individual’s previous personality characteristics (Item 97. Did you ever feel as 
if your personality changed?). 
 
Domain VIII: Arousal (Items 108-110) 
As already mentioned, increased arousal represent one of the three 
symptoms clusters that constitute PTSD (DSM-IV-TR, 2000). Individuals 
experience persistent feeling of anxiety or increased arousal that were not 
present before the trauma. These symptoms may include difficulty falling or 
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staying asleep that may be due to recurrent nightmares during which the 
traumatic event is relieved (DSM-IV-TR Criterion D1, 2000), hypervigilance 
(Criterion D4), and exaggerated startle response (Criterion D5). Some 
individuals report irritability or outbursts of anger (Criterion D2) or difficulty 
concentrating or completing tasks (Criterion D3). 
All “typical” symptoms reported in DSM-IV-TR criteria for PTSD has 
been reported in the SCI-TALS, besides adding subthreshold specifiers to each 
items that assess even milder responses of increased arousal. 
 
Domain VII: Maladaptive Copying (Items 98-105) 
PTSD can often be associated to the following constellation of 
symptoms that may occur and are more commonly seen in association with an 
interpersonal stressors (childhood sexual or physical abuse, domestic battering, 
being taken in hostage, incarceration as a prisoner of war or in a concentration 
camp, torture), as reported in DSM-IV-TR associated features to PTSD (2000): 
self destructive and impulsive behaviour; somatic complaints, feeling 
hopelessness and permanently damaged. All these features can often represent 
one of the major manifestations of the disorder that, if accurately investigated, 
can often even hide the presence of a post-traumatic symptomatology that the 
patients try not to express for the strong avoidance attitude of recalling.  
Moreover, literature on PTSD has enhanced the high risk for suicide, 
suicidal ideations or behaviours in patients with PTSD. This Domain is aimed 
at exploring the spectrum of maladaptive behaviours that the patient can 
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develop as consequence of the trauma and its impact on his psychological 
balance. The items of this Domain encompass the spectrum of these behaviours 
including the atypical ones also listed in the associated features of DSM-IV-
TR, in the light of a spectrum approach to self harming-suicidal behaviours 
(Did you ever…Item 98. stop taking care of yourself, for example, not getting 
enough rest or not eating right? …Item 99. stop taking prescribed medications 
or fail to follow-up with medical recommendations, such as appointments, 
diagnostic tests, or a diet? ….Item 104. intentionally scratch, cut, burn or hurt 
yourself…Item 105. attempt suicide?), and impulsive behaviours (Item 
101...engage in risk-taking behaviours, such as driving fast, promiscuous sex, 
hanging out in dangerous neighbourhoods?).  
Moreover, often patients develop substance or alcohol abuse as self 
medication of post-traumatic symptomatology. This is in fact the main reason 
for the relevant comorbidity between PTSD and substance and alcohol abuse 
disorders (Breslau et al., 2003). The SCI-TALS includes in this Domain the 
assessment of the presence of such behaviours (Item 100. Did you ever use 
alcohol or drugs or over-the-counter medications to calm yourself or to relieve 
emotional or physical pain?). 
Either of these latest complications have been recently reported as 
possible consequence of a traumatic experience, increasing the debate on the 
possible implications, or cause effective correlations, of a concomitant mood 
liability. 
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Domain IX: Personal Characteristics/Risk factors (Items 111-116) 
As already reported, individuals with PTSD may show associated 
constellations of symptoms that may occur and are more commonly seen in 
association with interpersonal stressor, such as feelings of hostility and change 
from individual’s previous personality characteristics (Pat-Horenczyk et al., 
2007). On the other hand, authors have tried to identify personality 
characteristics that may represent risk factors for the development of PTSD 
after trauma exposure (Heinrichs et al., 2005). 
The SCI-TALS is a lifetime instrument and this may also allow to 
detect post-traumatic reactions happened long time before assessment. For this 
reason at the time of evaluation it can be often possible to detect personality 
characteristics that may derive from changes related to the impact of the event, 
or, conversely, represent stable personality traits that the patient present before 
the event or loss occurred and that may account as risk factors for the 
development of the spectrum symptomatology explored in the SCI-TALS.  
  
In conclusions, the SCI-TALS is aimed at bringing to light an 
individual’s exposure to a range of threatening experiences, as well as a variety 
of potentially significant losses, and at assessing the acute reactions and 
persistent symptoms that may ensue from either type of life event. We 
underline that, similarly to our other spectrum measures, the SCI-TALS 
explores the presence/absence of psychopathological manifestations associated 
with syndromes that might occur during the lifetime of an individual. This 
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instrument lists a range of life events and assesses lifetime exposure to these, as 
well as a range of lifetime symptoms in the aftermath of the worst event. 
Therefore, the duration, clustering and severity criterion symptoms needed to 
make a diagnosis according to DSM-IV or ICD-10 cannot be determined. The 
SCI-TALS cannot replace a diagnostic interview, such as the SCID.  However 
this instrument provides information related to a range of subthreshold events 
that might have caused serious distress, as well as a broad array of clinical 
features associated with trauma and loss events. 
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4.     SCI-TALS MULTICENTER NATIONAL  
VALIDATION STUDY    
 
 
Aim of the study 
 
Primary aim of the present thesis is to describe the SCI-TALS and 
document its acceptability, reliability and validity. This was done through a 
multicenter national validation study, involving 6 Italian University 
Departments of Psychiatry (Pisa, Cagliari, Milano, Napoli, Sassari and Siena), 
coordinated by the 2nd Psychiatric Clinic of the Azienda Ospedaliero-
Universitaria Pisana, Pisa Italy, coordinated by Prof L. Dell’Osso and Dr. C. 
Carmassi. A consecutive group of 186 subjects was recruited, statistical 
analyses were performed on a subsample of 140 subjects who did not present 
any comorbidity between PTSD and CG. 
We administered the instrument to study participants who met DSM-IV 
diagnostic criteria for PTSD and/or CG (Shear et al., 2005), and to a sample of 
healthy controls without any current or lifetime psychiatric disorder. We tested 
the reliability by analysing the correlations between domains of the SCI-TALS 
and the internal consistency of domains themselves. The test-retest and inter-
rater reliability of the SCI-TALS were examined at Pisa site only. We 
examined the validity by testing whether the clinical samples showed  from 
those of the comparison group.  
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 Materials and Methods 
 
 The SCI-TALS was developed by the Italian-American team of 
researchers belonging to the “Spectrum” Project. Originally developed in 
English, the interview was then translated into Italian, back translated, and 
revised for inconsistencies between the two languages. In the present study we 
used the revised Italian version.  
 
Sample 
A consecutive group of 186 patients was recruited and analyses were 
performed on a subsample of 140 subjects who did not present any comorbidity 
between PTSD and CG. This latest sample included 92 out- and inpatients (48 
patients with PTSD and 44 with CG), presenting for treatment at one of the 6 
Italian University Departments of Psychiatry (Pisa, Cagliari, Milano, Napoli, 
Sassari and Siena), and 48 healthy Controls, collected at the same sites. 
Eligible patients were adult inviduals with a diagnosis of Post-Traumatic Stress 
Disorder (according to DSM-IV criteria, 1994) or complicated grief, 
determined by a score of at least 25 on the Inventory of Complicated Grief 
(Shear et al., 2005). Individuals with severe medical illness, neurological 
diseases, substance abuse or psychotic symptoms in the month preceding the 
index assessment, or inability to participate because of the severity of 
psychiatric symptoms were excluded. The final study sample included 48 
patients with PTSD and 44 with CG. We also recruited a comparison group of 
48 control subjects, without any Axis I psychiatric diagnoses. Controls were 
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individuals without any history of psychiatric disorders presenting at the 
Departments of Ophthalmology of the local Universities for a routine sight 
control, and their friends and relatives.  
Data for the present report were collected between May 2004 and 
December 2005. The Ethics Committee of the Azienda Ospedaliera 
Universitaria of Pisa approved all recruitment and assessment procedures. 
Eligible subjects provided written informed consent, after receiving a complete 
description of the study and having the opportunity to ask questions. Subjects 
were not paid for their participation in accordance to the Italian laws for 
clinical studies.  
 
Instruments and assessments 
The diagnostic assessment was conducted on patients and controls 
using the Structured Clinical Interview for DSM-IV axis-I disorders (SCID-I/P, 
First et al., 1995) and the SCI-TALS. by psychiatrists trained and certified in 
the use of the study instruments at the Department of Psychiatry of the 
University of Pisa. The Inventory of Complicated Grief (ICG, Prigerson et al., 
1995b) was administered to determine the presence of complicated grief, 
defined by a score of 25 or higher. The Impact of Event Scale (Horowitz et al., 
1979) was administered to assess the symptomatology related to post-traumatic 
stress disorder. 
The SCI-TALS includes 116 items exploring lifetime traumatic events 
or losses and lifetime symptoms, behaviours and personal characteristics that 
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might represent risk factors for the development of the disorder. The SCI-
TALS description has been previously reported (see The SCI-TALS instrument 
chapter).  
The acceptability of the SCI-TALS was determined using questions 
asking whether the interview was interesting, reassuring, distressing, and 
helpful for a better understanding of the disorder for either the patient or the 
physician. Items were rated on a 0-3 scale, where 0=not at all, 1= a little, 2= 
much, 3= very much. 
 
Statistical analyses  
The validity of the SCI-TALS was examined by comparing the mean 
scores of the domains among subjects with PTSD, CG and  controls, by using 
one-way analysis of variance followed by post-hoc comparisons with 
Dunnett’s C-test, that allows for heterogeneity of variance between groups. The 
alpha level was corrected for multiple comparisons (0.016=0.05/3). Analysis of 
covariance was performed to control for potential confounders such as age and 
gender. Comparisons of categorical variables across groups were conducted by 
using the 2x3 chi-square tests, followed by 2x2 chi-square tests. The reliability 
of the SCI-TALS was examined by analysing the correlations between domains 
and the internal consistency of domains. Kuder-Richardson coefficient, a 
variant of the alpha coefficient for dichotomous items (Nunnally & Bernstein, 
1994), was used to determine the internal consistency. Test-retest and inter-
rater reliability of the SCI-TALS was performed at Pisa site only, by having 
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different raters conduct a second SCI-TALS evaluation within 14 days of the 
initial assessment.  We examined reliability using the intraclass correlation 
coefficient. Shrout criteria (Shrout, 1998) were used to define the range of 
reliability: 0-0.10 virtually none, 0.11-0.40 slight, 0.41-0.60 fair, 0.61-0.80 
moderate, 0.81-1 substantial. Data analyses were carried out using SPSS 
12.0.1.  
 
 
Results 
 
Subjects 
Demographic and clinical characteristics of the study groups are 
provided in Table 1. Controls were younger than CG patients. The majority of 
patients with CG (84.1%) and of controls (64.6%) were females, while patients 
with PTSD were equally distributed by gender. Patients with CG were more 
likely to be widowed than the other groups, had a lower educational level and 
were less likely to be employed than controls,.  
As expected, CG patients had a significantly higher ICG total score 
compared to PTSD and controls (Table 1). 
 
Acceptability and  validity of the SCI-TALS  
The SCI-TALS was administered to patients and controls in one session 
of approximately 30 minutes. The acceptability of the interview was excellent: 
96.9% of participants rated it as much or very much interesting, 49.6% rated it 
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as much or very much reassuring, 51.8% and 82.5% found that it was helpful 
to better understand the patients’ own problems and to provide useful 
information to the physician, respectively. However, 32.8% of patients found 
the interview much or very much distressing. No one refused to participate and 
no participants failed to complete the interview. Mean SCI-TALS domain 
scores for each of the groups are provided in Table 2, together with the results 
of the one-way ANOVA and the post-hoc pairwise comparisons. The two 
patient groups did not differ on 6 out of 8 Domains (Table 2) and both scored 
significantly higher than controls. Interestingly, this was also true for number 
of loss events. PTSD and CG patients endorsed on average the same number of 
loss events.  However, consistent with evidence that CG is different from 
PTSD (Langner & Maercker, 2005; Shear et al., 2005), CG patients scored 
significantly higher that those with PTSD on Domain II: Grief reactions.  In 
contrast, those with CG endorsed a significantly lower number of potentially 
traumatic events, and did not differ from PTSD on re-experiencing, avoidance 
or hyper-arousal.  
Analysis of covariance was performed on the SCI-TALS domains to 
determine whether the differences between groups depended on gender and age 
imbalance. No association was found between age and the SCI-TALS domains. 
Gender was associated with the domains ‘grief reactions’, ‘maladaptive 
copying’ and ‘arousal’, but this association did not affect the differences 
among diagnostic groups.  
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Reliability of the SCI-TALS 
We examined the internal consistency of the domains and correlations 
of domains in the pooled sample of individuals with either PTSD or CG 
diagnosis (Table 3). All Kuder-Richardson coefficients exceeded the minimum 
standard of 0.50 suggested for group comparison by Helmstadter (1964).  
Additionally, all domains and 12 out of 16 sub-domains exceeded the 0.70 
standard for individual comparisons suggested by Nunnally (1978). For 
domains I, III and IX the internal consistency was not determined because 
these were checklists of events or of personality characteristics rather than 
symptoms. As reported in Table 4, correlations between domains were all 
positive and significant, with Pearson’s r ranging between 0.46 and 0.76 
(p<0.01).  
The test-retest and inter-rater reliability was excellent, with intraclass 
correlation coefficients values exceding .90 for each of the domains (Table 5). 
 
 
Discussion 
 
Results of this study provide evidence for the reliability and validity of 
a new spectrum instrument, the Structured Clinical Interview for Trauma and 
Loss Spectrum (SCI-TALS).  We developed this instrument to characterize the 
range of life events, acute event reactions and persistent symptoms and 
behavioural tendencies that occur among patients with post-traumatic stress 
disorder and the persistent grief disorder often referred to as complicated grief.   
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We found excellent inter-rater reliability of this interview when 
administered by different raters a mean of 2 weeks apart.  As expected, patients 
who met DSM-IV criteria for PTSD and ICG criteria for persistent grief 
disorder, scored significantly higher than a comparison control group.  This 
supports the validity of this instrument as a measure of trauma-loss spectrum. 
We believe that this interview, like the other spectrum instruments we 
have developed, has the advantage of helping patients understand themselves 
and feel understood by their clinician.  Moreover, lifetime spectrum symptoms 
of a range of mood and anxiety disorders were found to  contribute to 
impairment (Bazzichi et al., 2005; Fagiolini et al., 2005), to represent a risk 
factor for suicidality (Balestrieri et al., 2006), and to influence treatment 
outcome (Frank et al., 2000; Frank et al., 2002; Dell’Osso et al., 2007). 
We believe the spectrum approach provides a more specific description 
of the clinical features of each patient with potentially important implications 
for treatment choice and research. We also think that a less restrictive approach 
to the definition of the potentially traumatic events, than that defined in DSM-
IV, would particularly help clinicians to explore more accurately post-
traumatic stress conditions. Moreover, the evidence of a different profile for 
those suffering the consequences of trauma versus loss suggests that the 
spectrum approach might help identify specific phenotypes to be used in 
clinical, neurobiological and genetic studies. Further studies are warranted to 
assess the potential utility of this approach in clinical practice.  
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5. LIFETIME SUBTHRESHOLD MANIA 
COMORBIDITY AND PERIPHERAL 
BENZODIAZEPINE RECEPTOR (PBR) IN 
PTSD  
 
 
Introduction: Peripheral Benzodiazepine Receptor, 
Bipolar  disorder  and PTSD 
 
 
Post-traumatic stress disorder (PTSD) is a severe, invalidating and often 
chronic psychiatric condition (Kessler et al., 1995) which characteristics have 
been progressively defined in the last years. From its first codification in the 
Diagnostic and Statistical Manual of Mental Disorders-IIIrd edition in 1980, up 
to the latest DSM-IV-TR, the characteristics of either the provoking trauma and 
of the symptomatology have been more accurately described. These progresses 
led to an increasing recognition of PTSD in civilians (such as victims of rape, 
physical assault, natural disasters, motor vehicle accidents or other traumatic 
events not combat related), even if the majority of early studies had been 
originally developed on male military or combat veteran populations because 
of historical precedents and subject availability (Keane & Wolfe, 1990). 
Clinical studies reported prevalence rates in the general population ranging 
between 9.5% and 11.2% (Helzer et al., 1987; Breslau et al., 1991; Kessler et 
al., 1995). These data support the relevance of detecting potential risk factors 
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for the development of such an invaliding condition. Nevertheless, agreement 
among authors has been reported for only few potential risk factors, such as 
gender, number of previous traumatic experiences and acute symptoms such as 
peritraumatic dissociation. 
 Recently, increasing attention has been given to the role of mood 
comorbidity, and particularly that of Bipolar Disorder (BD), as potential risk 
factor for PTSD onset. In psychiatric literature, consistent data have already 
shown the presence of high rates of comorbidity between the two disorders, 
suggesting higher vulnerability for the development of PTSD in patients with 
bipolar disorder (BD) (Otto et al., 2004).  
In line with these studies, authors have started debating whether BD 
might represent a risk factor for PTSD (Pollack et al., 2006) or if this 
comorbidity might be due to the fact that patients with BD frequently present 
characteristics that have been identified as risk factors for PTSD, such as: 
trauma exposure (Darves-Bornoz et al., 1995; Mueser et al., 1998; Neria et al., 
2002), depression and hypomania (Schnurr et al., 1993), comorbid anxiety 
disorders (Pollack et al., 2006).  
Recently Pollock and collaborators (Pollack et al., 2006), examining 
PTSD onset following indirect exposure to the September 11, 2001, terrorist 
attacks, in a cohort of patients with BD (enrolled in the on-going longitudinal 
study Systematic Treatment Enhancement Program for Bipolar Disorder, 
STEP-BD), have reported, for the first time, that presence of manic state at the 
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time of exposure may represent the most critical risk factor for the onset of 
persistent PTSD. 
Besides progresses in clinical assessments, biochemical studies have 
attempted to find reliable biological markers of post-traumatic stress 
conditions. Although the findings have been highly variable (de Kloet et al., 
2006), a great number of data have suggested the presence of characteristic 
alterations in the function of hypothalamic-pituitary-adrenal (HPA) axis 
(Yehuda et al., 2000; Nemeroff et al., 2006), the network which coordinates 
steroid metabolism during the physiological responses. 
The HPA axis, which consists in the hypothalamus, the pituitary gland 
and the adrenal gland, constitute the main stress response system. It receives 
information from the amygdala and the hippocampus, as well as from the 
autonomic nervous system (Holsboer, 2001), and in turn, it coordinates stress 
responses. Moreover, it can trigger hormonal cascade: the hypothalamus 
releases the corticotrophin releasing hormone (CRH), which stimulates the 
discharge of adrenocorticotropin releasing hormone (ACTH) from the pituitary 
gland. Then ACTH actives the steroid synthesis within the adrenal cortex from 
pregnenolone down to the glucocorticoid cortisol, which is subsequently 
secreted into the blood circulation. When the glucocorticoid blood 
concentration overpass a certain value, the cortisol provides negative feedback 
at the level of the hypothalamus, the pituitary and the hippocampus, blocking 
the stress response. 
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The HPA axis complexity is the result of the adaptive mechanisms 
needed to maintain body homeostasis also during strong stress conditions. Such 
hormonal and physical responses, organized by the HPA axis, have protective 
functions in acute stress states, but they can be harmful if deregulated. In fact, 
if stress hormones are overproduced for long periods of time without control, 
they can damage peripheral and central tissues, causing physical and mental 
diseases (McEwen, 2002). For example, excessively high corticoid levels 
induce cell atrophy by glutamate damage in the hippocampus, a brain area 
particularly important for memory and learning, which has a high density of 
glucocorticoid receptors (Lupien et al., 1998). 
In patients with PTSD, highly variable alterations of the HPA axis have 
been reported, despite modifications of this system are actually certain in this 
disorder. Cortisol in fact, represents the principal steroid hormone in humans 
and the primary regulator of resting activity of the HPA axis. Some studies 
found high 24-h urinary cortisol levels in patients with PTSD (Lemieux & Coe, 
1995; Pitman and Orr, 1990; Rasmusson et al., 2001), weather other reported 
low values (Yehuda et al., 2000), or also no differences versus controls (Baker 
et al., 1999; Kosten et al., 1990) 
Recently, since a glucocorticoid levels elevation inhibits memory 
retrieval in animals and healthy human subjects, it has been suggested the 
administration of low-dose cortisol treatment (10 mg/day for 1 month) to 
obtained beneficial effects attenuating the incidence or intensity of traumatic 
memories, a cardinal symptom of PTSD (Aerni et al., 2004). 
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It’s known that physical or emotional stress, besides cortisol level 
changes, can produce severe alterations in serum levels of other steroids 
(Charney, 2004). The dehydroepiandrosterone (DHEA) is an adrenal steroid 
secreted episodically and synchronously with cortisol. DHEA and its sulphate 
derivate (DHEAS), have been shown to determine a bimodal modulation effect 
on GABAA receptor: a positive allosteric modulation at nanomolar 
concentrations and a negative one at micromolar concentrations. Such 
modulating effects are mirrored in behavioural setting (Majewska, 1992). 
Elevated circulatory levels of DHEA and DHEAS have been detected in 
plasma of patients with combat-related PTSD (Spivak et al, 2000). On the other 
hand, decreased concentrations of both DHEA and DHEAS have been reported 
in stress characteristic paradigms as depression and chronic inflammation 
(Charalampopoulos et al, 2005). 
The steroid biosynthesis occurs mainly in the adrenal gland, but also in 
the glial cells of the central nervous system, in which are synthesized the so-
called neurosteroids. In both tissues, the pivotal limiting step in the synthesis is 
represented by the cholesterol transport within the mitochondria which is 
realized through a mitochondrial pore. Cholesterol is then converted in 
pregnenolone, catalyzed by the cytochrome P450 SCC present in the inner 
mitochondrial membrane, that then undergoes to metabolic transformations in 
the endoplasmic reticulum, giving rise to other steroids.  
The mitochondrial translocator protein (Peripheral Benzodiazepine 
Receptor, PBR) has been demonstrated to be a component of such pore, 
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essential for the cholesterol crossing through the outer mitochondrial 
membrane, behaving either as a channel or as a chaperon (Culty et al., 1999; 
Lacapere & Papadopoulos, 2003). In fact, it has been suggested that PBR could 
form a channel allowing cholesterol to cross over the outer mitochondrial 
membrane (Culty et al., 1999), although the most accepted hypothesis is that 
PBR functions as chaperon which bind cholesterol with high affinity (Lacapere 
et al., 2003). 
PBR density has been found altered in different pathological conditions, 
such as cancer and neurological illnesses, and in many psychiatric disorders 
(Papadopoulos et al., 2006) as well as in stress responses: up-regulation has 
been shown in acute stress conditions while down-regulation in repeated or 
chronic stress (Weizman et al., 1994; Gavish et al., 1996; Droogleever Fortuyn 
et al., 2004; Veenman & Gavish, 2006).  
The binding of PBR ligands, inducing cholesterol transport into 
mitochondria and steroid formation by glial cells, leads to the formation of 
pregnane neurosteroids, such as allopregnanolone and pregnanolone, which 
positively modulate the functions of the GABAA receptor and have anxiolytic 
effects, as shown in animal models of anxiety (Papadopoulos, 2006).  
In rats, acute stress has resulted in increase in PBR density in the brain, 
whereas repeated swim stress (Burgin et al., 1996), repeated foot shock 
(Drugan et al., 1988) and food deprivation stress (Weizman et al., 1990) led 
towards a reduction in PBR density, suggesting that such changes may be due 
to a receptor density compensatory shift to accommodate the demand of 
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steroids under stress conditions (Drugan, 1996; Drugan et al., 1993; Weizman 
& Gavish, 1993; Gavish et al., 1999).  
In human subjects, lower levels of binding to the PBR have been 
reported in the platelets of patients with anxiety (Gavish, 1999, Marazziti et al., 
1994). Moreover, these levels increased after subsequent treatment with 
diazepam (Weizman et al., 1987; Gavish, 1999), suggesting that PBR ligands 
could prevent psychiatric disorders that arise from a stress-induced imbalance 
of CNS function (Papadopoulos et al., 2006).  
Only a few studies have investigated platelet PBR levels in patients 
with PTSD, reporting lower receptor levels, thus all have been conducted in 
veterans population samples during or after chronic war stress, (Weizman et 
al., 1994; Gavish et al., 1996, 1999). 
 
 
Aim of the study 
 
 Since mitochondrial PBR is a key element in the steroidogenesis rate-
limiting step, and alterations in the HPA axis seems to represent a 
characteristic finding of PTSD patients, secondary aim of the study reported in 
the present thesis was to explore lymphomonocyte mitochondrial PBR 
alterations in PTSD patients form the general population with not-combat 
related trauma. Since PBR is presented in whole cell membranes (plasmatic, 
nuclear and mitochondrial), we focused on the mitochondrial PBR density, in 
order to take account of the PBR amount mainly involved in steroid synthesis. 
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The study was conduced in a sample of Italian civilian patients affected by 
PTSD. All patients had been exposed to different type of traumas, all not-war 
related. The groups of subjects were also compared to a sample of healthy 
subjects, without any axis I current or lifetime psychiatric disorder, belonging 
to the same community background. 
Further, aim of the present study was to detect, in the same group of 
subjects, the possible correlations between the PBR equilibrium binding kinetic 
parameters alterations and the presence of lifetime manic/hypomanic 
symptoms. In the last years increasing evidence supports the possible clinical 
relevance of detecting even mild manic-hypomanic symptoms in clinical 
populations, and in line with these studies new assessment instruments have 
been developed, such as the Mood-Spectrum Self Report (MOODS-SR) 
lifetime version (Dell'Osso et al., 2002; Cassano et al., 2004). This latest is an 
instrument that focuses on lifetime manic and depressive symptoms, 
characteristics, traits and lifestyles that characterize threshold and sub-
threshold mood episodes related to Axis I mood disorders. Correlations 
between PBR changes and lifetime Mood Spectrum manic/hypomanic or 
depressive items in patients with PTSD diagnosis were investigated in order to 
corroborate the role of mood alterations as risk factors for adverse sequel 
following exposure to trauma. 
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Materials and Methods 
 
Subjects 
The data of the present report were collected at Department of 
Psychiatry, Neurobiology, Pharmacology and Biotechnology of the University 
of Pisa. The whole sample included 35 subjects: 22 with PTSD, and a 
comparison group of 13 control subjects, without any Axis I lifetime or current 
psychiatric diagnoses. Eligible subjects included new and continuing patients, 
over 18 years of age, with a diagnosis of PTSD (according to DSM-IV-TR 
criteria, 2000) and individuals without any history of psychiatric disorders 
(controls). Exclusion criteria for patients and controls were auto-immune, 
inflammatory or endocrine disorders, obesity, alcohol or drug abuse, on-going 
use of contraceptive drugs. Patients were asked to have discontinued any 
pharmacological treatment, including psychotropic medications, at least 4 
weeks prior to entering the study. The study design was carried out in 
accordance with the latest version of the Declaration of Helsinki and it was 
reviewed and approved by the ethical committee of the Azienda Ospedaliero-
Universitaria Pisana, Pisa, Italy. After complete description of the study, a 
written informed consent of the participants was obtained. 
 
Instruments and assessments 
Patients were assessed by: the Structured Clinical Interview for DSM-
IV axis-I disorders (SCID-I/P, 25); the Impact of Event Scale (IES, Horowitz et 
 81 
al., 1979), in order to assess post traumatic on-going symptom severity; and the 
MOOD-SR (Dell'Osso et al., 2002) in order to assess the lifetime mood 
spectrum symptomatology, and in particular the manic/hypomanic and 
depressive spectrum symptoms. All assessments were conducted by 
psychiatrists or residents in psychiatry, who were trained and certified in the 
use of the study instruments at the Department of Psychiatry, Neurobiology, 
Pharmacology and Biotechnology of the University of Pisa. 
 
Biological Sample Collecting 
Blood samples (20 ml) were collected from both patients and controls, 
between 9 and 10.30 AM, after a overnight fast. Blood samples were drawn 
into test tubes containing Li-Heparin and than processed for PBMC 
purification, using differential centrifugations with Lymphoprep (Axis-Shield 
PoC AS, Oslo, Norway) according to the method of Boyum (Mueser et al., 
1998). The final mononuclear cell pellet was stored at –80°C until analyses. 
The Ethics Committee of the Azienda Ospedaliera Universitaria of Pisa 
approved all recruitment and assessment procedures (N°00019916). Eligible 
subjects provided written informed consent, after receiving a complete 
description of the study and having the opportunity to ask questions. 
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Radio-ligand binding assays on lymphomonocyte mitochondria 
membranes 
Mitochondria membranes from the mononuclear cells were prepared as 
previously described (Nemeroff et al., 2006) with minor modifications. In 
brief, the lymphomonocyte pellet was homogenized in an adequate ice-cold 
buffer, by using a Potter Elvehjem glass homogenizer, and centrifuged at 800 x 
g for 10 min at 4°C. After supernatant centrifugation (10,000 x g for 10 min at 
4°C), the resulting mitochondria pellet was suspended in an adequate buffer 
and protein concentration was estimated by the method described by Lowry et 
al. (Neria et al. 2002) using bovine serum albumin as standard. 
In radio-ligand binding assays, [3H]PK11195, a classical PBR ligand, 
was used for the determination of the PBR equilibrium binding parameters in 
lymphomonocyte mitochondria membranes (Scatchard Analyses). 
In brief, [3H]PK11195 binding assays were conduced incubating 
membrane aliquots (30 µg of protein) with increasing [3H]PK11195 
concentrations (0,5 nM-20 nM). Non specific binding was determined in the 
presence of 1 M of unlabeled PK11195. Samples were incubated in duplicate 
for 90 min at 0°C. 
After incubation time, samples were rapidly filtered under vacuum 
through GF/C glass fibre filters to separate the bound and the unbound ligand. 
After being washed three times with 4 ml of assay buffer, radioactivity trapped 
on the filter was measured in a liquid scintillation counter (TopCount; 
PerkinElmer Life and Analytical Sciences). 
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Data Analysis 
Scatchard analysis of [3H]PK11195 saturation binding data were 
performed using Kell RadLig for Windows 6.0 (Copyright 1997-1999 Biosoft 
and G.A. McPherson). 
Statistical analysis was executed using the Graph-Pad Prism 4 software 
(Graph-Pad Software Inc, San Diego, CA); analyses was performed by the 
unpaired Student’s t test, in order to compare demographic, clinical (totals and 
subdomain scores of IES and MOODS-SR) and biochemical (PBR Kd and 
Bmax) characteristics between patients and controls. Linear regression analysis 
with Pearson test was performed in order to evaluate possible correlations 
between PBR Bmax and demographic and clinical (total and subdomain scores 
of IES and MOODS-SR) in patients with PTSD. All tests were two-tailed and a 
p value <0.05 was considered statistically significant. All data are presented as 
mean±SD. 
 
 
 Results 
 
 The study sample included 35 subjects: 22 patients with PTSD and a 
comparison group of 13 control subjects, without any Axis I current or lifetime 
psychiatric diagnosis. The demographic and clinical characteristics of the study 
groups are provided in Table 6. Patients and controls were mostly females 
(59,09% and 69.23% respectively), mean age was 44.77±14.10 (mean±SD) and 
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35.08±11.96 years, respectively, and a significantly lower proportion of PTSD 
patients than controls reported more than 8 years of education (63,64% versus 
76,92% respectively, p<0.05). 
All patients presented a diagnosis of chronic PTSD and mean duration 
of time since the triggering trauma was 82,86±125.9 months (mean±SD), 
moreover, 53.8% of patients reported to have experienced one single trauma, as 
defined in accordance to DSM-IV-TR criterion A for PTSD diagnosis, while 
46.2% reported to have experienced more than one trauma in their lifetime. For 
what is concerned with the type of index trauma experienced by patients with 
PTSD: 8 (36.4%) had experienced an assaultive violence, 10 (45.4%) an injury 
or shock, while 4 (18.2%) the death of loved one. Among controls, only 5 
subjects had experienced a traumatic event during their lifetime with: 1 (7.7%) 
patient having experienced an assaultive violence, 1 (7.7%) an injury or shock, 
and 3 (20%) the death of loved one.  
As expected, patients presented significant higher scores than controls 
in the Impact of Event Scale total score (28.95±13.55 versus 17.38±3.885, 
p<0.01), and in the Intrusive (14.57±6.911 versus 8.462±2.504, p<0.005) and 
Avoidance (14.38±7.039 versus 8.923±1.553, p<0.05) subscales (Table 6). 
Scatchard analysis of [3H]PK11195 saturation binding data performed 
in control and patient lymphomonocytes showed Kd value of 8.035±2.583 and 
6.580±2.865 (mean±SD) nanomolar, respectively, and a Bmax value of 
7991±1258 and 5707±1828 fmoli/mg of proteins, respectively. The Scatter 
grams of individual PBR Bmax values obtained from patients and controls are 
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illustrated in Figure 1. Unpaired t-test analysis demonstrated a highly 
significant decrease in Bmax values (p<0,0005) in patients with respect to 
control subjects, while the Kd values were not significantly different in the two 
groups. 
The correlation analysis performed by using Pearson test, between PBR 
Bmax and demographic and clinical parameters (Table 7), showed significant 
inverse correlation between PBR Bmax and the Total Manic component of the 
Mood Spectrum (p<0,05), while a p value close to significance was also 
reported for the inverse correlation between the receptor density and the 
Cognition Manic domain. 
 
 
Discussion 
 
Along with the progressive delineation of PTSD diagnostic criteria, 
since its first appearance in DSM-III, an increasing number of studies have 
reported the incidence of this disorder in general population samples, rising the 
relevance of possible biological markers of the disorder that could support the 
diagnosis and maybe helping in delineating strategies for future research. 
Biological markers have been investigated as supports for the clinical 
diagnosis, and among these the PBR was found altered in mental disorders, 
particularly stress related. Previous studies assayed PBR levels in blood cells of 
healthy controls during and following stressful situations, such as immediately 
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after an exam, showing that PBR density increased in students following 
academic examination (Droogleever Fortuyn et al., 2004; Karp et al., 1989; 
Nudmamud et a., 2000); on the contrary platelet PBR density appeared to be 
reduced after repeated parachute jumps during parachute training of soldiers 
(Dar et al., 1991). These findings have suggested that PBR density in blood 
cells can be increased in acute stress, but decreased under chronic stress 
conditions as occur with anxiety disorders (Veenman & Gavish, 2006). In 
general anxiety disorder, panic disorder and PTSD a lower platelet PBR levels 
have been detected (Veenman & Gavish, 2006). Thus, PBR alterations are not 
uniform among the anxiety disorder but restricted to those disorders presenting 
a persistent activation of the autonomic nervous system (Gavish et al., 1996). 
Basic studies in rats have suggested that the PBR stress-changes may be 
due to a receptor density compensatory shift to accommodate the demand of 
steroids under stress conditions (Drugan, 1996; Drugan et al., 1993; Weizman 
& Gavish, 1993; Gavish et al., 1999). 
Not surprisingly, PBR alterations have been investigated in subjects 
with PTSD, but the only study exploring alterations in platelet PBR of patients 
has been conduced in a special population, as all exposed to war stress 
(Weizman et al., 1994; Gavish et al., 1996). Weizman and colleagues 
(Weizman et al., 1994) have explored PBR alterations in soldiers before, 
during and immediately after exposure to repeated missile attacks during the 
Persian Gulf war, in conditions of acute and continued stress. In a later study, 
the same authors analysed a subgroup of the same sample, after two years from 
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the end of the war, evidencing a decrease in PBR density, but no correlation 
between the receptor and IES scores.  
To our knowledge, this is the first study investigating PBR alterations 
in a group of civilian patients that reported a PTSD diagnosis not related to war 
traumas, comparing the receptor among subjects with chronic PTSD arisen 
after exposure to different types of traumas. Moreover, this is the first study in 
which PBR density determination was conduced only on mitochondrial 
membranes, assuring the PBR amount estimated is involved in the biosynthesis 
of steroids. 
Our results showed a significant decrease in mitochondrial PBR density 
in the lymphomonocytes of civilian trauma victims with diagnosis of PTSD, 
according to data obtained in war-related PTSD patients. Further, in 
accordance to the findings reported by Weizman et colleagues (Weizman et al., 
1994), we did not also evidenced any correlation between the receptor density 
and IES scores. 
Since increasing data have reported the possibility of a relevant 
correlation between the presence of a manic or hypomanic state during 
exposure to traumatic events and the subsequent onset of PTSD (Otto et al., 
2004), we investigated if the presence of lifetime manic/hypomanic spectrum 
symptoms, indicating the presence of mood vulnerability, could be correlated 
with PBR density decrease in civil patients with PTSD. 
Since subjects affected by bipolar disorders are more sensible to 
psychophysical stress, we have chosen to assess possible correlations between 
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PBR and mood symptoms using a sharpened instrument: the Mood Spectrum-
Self Report (Dell'Osso et  al., 2002). We enhanced a significant correlation 
between PBR Bmax and total Mania values. In particular, patients with PTSD 
presenting the highest number of lifetime manic/hypomanic items showed the 
lowest PBR density. 
In relation to mood disorders, no difference has been reported in 
platelet PBR density of subjects with major depression, with respect to 
controls. No studies are available about PBR in bipolar disorders, but in this 
psychiatric disease abnormalities of the HPA axis functions are well 
documented (Gavish et al., 1999; Watson et al., 2004).  
It has been reported that high levels of circulating corticosteroids often 
induce psychiatric syndromes, conventionally known as steroid psychosis, and 
the first mood episode was often manic or hypomanic. Lewis and Smith (Lewis 
& Smith, 1983) reported seven manic, one depressive and two psychotic 
episodes from original series of steroid psychosis. Since PBR plays a important 
role in steroidogenesis, the chronic stress-induced decrease in PBR density 
could be the reflex of a neuroendocrine defence mechanism that affects the 
mitochondrial cholesterol transport and the stress-induced glucocorticoid 
production (Weizman & Gavish, 1993). The modifications in PBR kinetic 
parameters might account for the alterations in the levels of steroids observed 
in PTSD v and/or manic/hypomanic symptoms. Further studies are needed to 
better clarify this correlation. 
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6. CONCLUSIONS 
 
 
Being exposed to life-threatening events represents an increasingly 
given human existence. Recent epidemiological studies confirm increasing 
rates of exposure in civil populations, but luckily, only a minority of the people 
exposed goes on to develop post-traumatic stress conditions. Nevertheless, an 
increasing prevalence of subclinical and subsyndromal forms in the general 
population is progressively emphasized as consequence of the burden of seek 
for treatment and impairment associated. This has led researcher to highlight 
these subsyndromal expressions of post-traumatic reaction showing and to 
investigate their clinical relevance.  
Further, emerging literature documents the importance of the so-called 
“low-magnitude” or subthreshold events (e.g., divorce, serious illness and 
financial reverses) in determining post-traumatic stress reactions (Breslau and 
Davis, 1987; Solomon and Canino, 1990; Moreau & Zisook, 2002), increasing 
the never ending debate over the definition of the “nature” of an event in order 
to define it as traumatic. Higher relevance to the role of subjective vulnerability 
has been highlighted by these studies. This latest concept gives post-traumatic 
condition a particular importance for a better understanding of the continuum 
between genetically predetermined disorders and environmentally induced 
ones, in light with the actual debate on the research over new reliable models 
 90 
for clinical phenotypes other that the misleading ones suggested by the rigid 
current nomenclature. 
The results of the present thesis demonstrate the validity of a new 
assessment instrument, the Structured clinical interview for Trauma and Loss 
Spectrum, corroborating the relevance of a spectrum approach to post-
traumatic stress conditions, including CG. 
The SCI-TALS showed to be a valid and reliable instrument, able to 
provide a more specific description of patients’ clinical features giving 
information on a broad spectrum of trauma, loss events and related symptoms 
beyond those covered by existing instruments. A less restrictive approach to 
the definition of the potentially traumatic events than that defined in DSM-IV, 
as reported by SCI-TALS, would particularly help clinicians to more 
accurately explore post-traumatic stress conditions. Moreover, the evidence of 
a different profile for those suffering the consequences of trauma versus loss 
suggests that the spectrum approach might help identify specific phenotypes to 
be used in clinical, neurobiological and genetic studies.  
Further, in line with studies enhancing the need for neurobiological 
markers for a better understanding of either full blown and subsyndromal 
forms, the significant decrease in platelet PBR levels found in civilian patients 
with PTSD supports a role for this biochemical parameter in clinical 
assessments. Moreover, the correlation between this alteration and the presence 
of lifetime manic spectrum symptoms enhances the possible role of  mood 
spectrum symptomatology on PTSD onset, and corroborates the relevance of 
 91 
an accurate assessment of manic-hypomanic spectrum symptoms as risk factors 
for PTSD onset.  
To our knowledge, this is the first study investigating PBR alterations 
in a group of civilian patients that reported a PTSD diagnosis not related to war 
traumas, comparing the receptor among subjects with chronic PTSD arisen 
after exposure to different types of traumas. This may help in characterizing 
the disorder independently for the provoking event, supporting the role of 
subjective vulnerability. Moreover, this is the first study in which PBR density 
determination was conduced only on mitochondrial membranes, assuring the 
PBR amount estimated is involved in the biosynthesis of steroids. 
Further studies are warranted to assess the potential utility of this 
spectrum approach to PTSD and CG in clinical practice and to confirm the role 
of biological markers, such as PBR, in helping to increase the knowledge on 
the pathogenesis of these disorders and to allow more efficacious treatments.  
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Table 3. Internal consistency (Kuder-Richardson coefficient) of the SCI-TALS domains  
 
 #ITEMS KR-20 
I – Loss events 10 / 
II – Grief reactions
 
27 0.916 
III – Potentially traumatic events 21 / 
IV – Reaction to losses or upsetting events 18 0.863 
V – Re-experiencing 9 0.809 
VI – Avoidance and Numbing 11 0.858 
VII – Maladaptive coping 8 0.773 
VIII – Arousal 6 0.789 
IX – Personal Characteristics-Risk Factors 7 / 
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Table 4. Pearson’s correlations between SCI-TALS domains 
        ** p<0.01 
 
 
 
 
 
 
 
Domains 
 
IV  
Reaction to 
losses or 
upsetting 
events 
V 
Re-
experiencin
g 
VI  
Avoidance 
and 
Numbing 
VII  
Maladaptive 
coping 
VIII  
Arousal 
II - Grief reactions
 
0.549** 0.538** 0.545** 0.468** 0.521** 
IV – Reaction to 
losses or upsetting 
events 
 0.709** 0.710** 0.535** 0.722** 
V – Re-
experiencing 
  0.762** 0.528** 0.706** 
VI – Avoidance 
and Numbing 
   0.541** 0.676** 
VII – Maladaptive 
coping 
    0.567** 
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Table 5. Test-retest and inter-rater reliability.  
 
 
 
 
 
 
 
 
 
INTRACLASS 
CORRELATION 
COEFFICIENT 
I – Loss events .975 
II – Grief reactions
 
.992 
III – Potentially traumatic events .974 
IV – Reaction to losses or upsetting events .981 
V – Re-experiencing .975 
VI – Avoidance and Numbing .995 
VII – Maladaptive coping .993 
VIII – Arousal .972 
IX – Personal Characteristics-Risk Factors .969 
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Table 6. Demographic, clinical and biochemical characteristics of the study 
samples. 
 
 PTSD 
N=22 
Controls 
N=13 
 
 % %  
Female 59,09 69,23 p<0.005 
Married/living with partner 59,09 30,77 p<0.005 
>8 y. of education 63,64 76,92 p<0.05 
Employed full/part time 86,36 76,92 p<0.05 
Unemployed 9,09 7,69 Ns  
Type of index trauma 
        Assaultive violence 
        Other injury/Shock 
        Sudden death of a loved one 
 
36,4 (N=8) 
45,4 (N=10) 
18,2 (N=4) 
 
7,7 (N=1) 
7,7 (N=1) 
20 (N=3) 
 
 
 Mean±SD Mean±SD p 
Age (years) 44,77±14,10 35,08±11,96 p<0,05 
IES          Total score 28,95±13,55 17,38±3,885 p<0,01 
                Intrusive subscale 14,57±6,911 8,462±2,504 p<0,005 
                Avoidance subscale 14,38±7,39 8,923±1,553 p<0,05 
MOODS  Total score 77,95±35,25 63,62±35,79 Ns 
                Mood Depressive 11,43±7,131 7,846±6,039 Ns 
                Mood Manic 12,86±7,378 8,000±6,245 p=0,057 
                Energy Depressive 5,810±3,881 3,923±3,278 p<0,05 
                Energy Manic 2,905±2,948 1,000±1,633 p<0,05 
                Cognition Depressive 21,62±5,053 26,07±2,530 Ns 
                Cognition Manic 12,43±6,384 7,462±6,995 p<0,05 
                Depressive Items Total 37,19±17,00 36,31±20,62 Ns 
                Manic Items Total 28,19±14,44 16,46±13,50 P<0,05 
                Rithmicity 12,57±7,194 10,85±7,198 Ns  
PBR Bmax (fmol/protein mg) 5707±1828 7991±1258 <0.0005 
PBR Kd (nM) 6.580±2,865 8.035±2,583 Ns 
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Table 7. Pearson test correlation between PBR Bmax and demographic and clinical (total 
and subdomain scores of IES and MOODS-SR) in patients with PTSD. A Pearson test p 
value <0.05 was considered statistically significant. 
 
PTSD 
N=22 
Parameters Pearson r P value (two-tailed) 
Age 0,04524 0,8415      Ns 
Sex 0,1944 0,3984      Ns 
N° of traumas -0,3279 0,1363      Ns 
Time from trauma 0,07020 0,7562      Ns 
IES               Total score -0,1274 0,5821      Ns 
                     Intrusive subscale -0,2010 0,3822      Ns 
                     Avoidance subscale -0,04793 0,8365      Ns 
MOODS       Total score -0,2688 0,2388      Ns 
                     Mood Depressive -0,3263 0,1489      Ns 
                     Mood Manic -0,3867 0,0833      Ns 
                     Energy Depressive -0,06056 0,7943      Ns 
                     Energy Manic -0,3613 0,1076      Ns 
                     Cognition Depressive -0,07248 0,7549      Ns 
                     Cognition Manic -0,4161 0,0607 
                     Total Depressive   -0,09401 0,6852      Ns 
                     Total Manic -0,4552 0,0381       p<0,05 
                     Rithmicity -0,1807 0,4330      Ns 
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Figure 1. [
3
H]PK11195 Bmax values in lymphomonocyte mitochondrial membranes from 
patients with PTSD and controls. Each point represents an individual subject. The 
difference in Bmax values between controls and patients is statistically significant (p<0.05). 
a
Significant difference (t=3,972 df= 33, p=0,0004) 
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9. APPENDIX: SCI-TALS 
 
 
Structured Clinical Interview for Trauma and Loss Spectrum 
 
 
INTRODUCTION:  
Thank you for coming in to talk with me today.  The interview we are going to do is 
focused on losses and upsetting events that you may or may not have experienced in your 
life and your reactions to them.  We want to know whether you had these reactions at any 
time, even if it was a long time ago.   There are eight sections of the interview and it should 
take us about half an hour to complete it.  Do you have any questions before we start? 
 
Interviewer: I am going to begin by asking you about some losses that you may have 
experienced.    
 
DOMAIN I.  LOSS EVENTS 
 
Did any of the following things ever happen to you? 
1. 
…a change in homes, caregivers, schools, jobs, etc. that you didn’t want or 
regretted? 
Yes No 
2. 
…separation from a close friend, romantic partner, or family member 
because of relocation, hospitalization, military service, or because of an 
argument or disagreement? 
Yes No 
3. …a painful break-up with a romantic partner or a close friend? Yes No 
4. …a divorce in your family? Yes No 
5. …the loss or death of a cherished pet?  Yes No 
6. …being neglected or abandoned? Yes No 
7.  …the death of a close friend or relative? Yes No 
8.  
…a miscarriage, stillbirth, or abortion?  Note to interviewer:  can apply to 
male subjects as well as female.  
 Yes No 
 
9.  Did you lose your sight, hearing, or have a serious disability?   Yes  No 
10. Did you have any other important losses, whether people, places or things 
that I haven’t asked you about?   What were they? 
Record here: 
 
Yes No 
 
Note to interviewer: If the subject has not endorsed any losses up to this point, skip to 
Domain III (Traumatic Events).   
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DOMAIN II.  GRIEF REACTIONS 
 
Since you experienced these losses, have you ever had a period of time when… 
11. …you had a lot of trouble accepting the loss? Yes No 
12. …you constantly longed for the way things used to be? Yes No 
13. 
…you longed or searched for a loved one or a familiar place in a way that 
seemed excessive and/or uncontrollable?  
Yes No 
14. …you daydreamed a lot about the person or thing you lost? Yes No 
15. 
…you were bothered more than you expected by feelings of grief, or you had 
frequent intense pangs of grief? 
Yes No 
16. …you felt that your life had no purpose without the person or thing you lost? Yes No 
17. …grief interfered with your ability to function? Yes No 
18. …your family or friends told you that it was time to get over it? Yes No 
 
Did you ever have a period of time when you… 
19. …had a great need to reminisce about the person, place or thing you lost? Yes No 
20. 
…spent a lot of time with objects that reminded you of the person, place or 
thing you lost, such as pictures, scrap books, mementos, etc.?  
Yes No 
21. 
…felt compelled to visit places that reminded you of the person, place or 
thing you lost? 
Yes No 
22. …had recurrent upsetting images of the person, place or thing you lost? Yes No 
23. 
…were extremely sad thinking about how special the person, place or thing 
was? 
Yes No 
24. 
…avoided going to the cemetery, going to the place where the person died, 
or any other place related to the death? 
Yes No 
25. 
…could not remember the things you loved, admired or enjoyed about the 
person you lost? 
Yes No 
26. …thought you saw, heard or talked with the person(s) you lost? Yes No 
27. …kept thinking you could have prevented the separation or death? Yes No 
28. 
…blamed yourself for doing something, or not doing something, that you 
think might have helped the person(s) you lost?  
Yes No 
29. …felt that if you stopped grieving you would lose the person(s) forever? Yes No 
30. 
…felt that it would be wrong if your grief were less intense, as though you 
were betraying the person(s) you lost? 
Yes No 
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Now I’m going to ask you some questions about how you are now. 
Are you the type of person or have others told you that you… 
31. …enjoy or find satisfaction in taking care of people? Yes No 
32. 
…feel the need to always have someone to take care of (or feel lost or 
aimless if there isn’t someone to take care of)? 
Yes No 
33. …find it difficult to ask for help? Yes No 
34. …tend to think that people you are close to will always be there? Yes No 
35. …form very close attachments to people and things? Yes No 
36. …have the feeling that you can’t live without the people close to you? Yes No 
37. …get very upset when you lose things that you are attached to?  Yes No 
 
DOMAIN III.  POTENTIALLY TRAUMATIC EVENTS 
 
Now I’d like to ask you about some upsetting events that may have happened to you.  
Note to interviewer: The point in asking these questions is simply to identify traumatic 
events, not to characterize them fully.  [
c
 indicates criterion symptoms]. 
 
Did any of the following things ever happen to you? 
38. …repeated failure in school or at work?  Yes No 
39. …repeated severe arguments in your family? Yes No 
40. …being repeatedly teased or harassed? Yes No 
41. …being beaten up or physically threatened? Yes No 
42. …unwanted sexual advances? Yes No 
43. …physical or sexual abuse?
 c
 Yes No 
44. …rape?
 c
 Yes No 
45. …being the object of a lawsuit or disciplinary action? Yes No 
46. …being arrested or indicted for a crime? Yes No 
47. 
…an event that seriously threatened your well-being, employment, 
professional status, social standing or financial security?  
Yes No 
48. 
…a serious medical illness, surgery, or other distressing medical 
procedure?
 c
 
Yes No 
49. 
…a serious accident or injury (for example, an automobile accident, or 
plane crash)?
 c
 
Yes No 
50. …a disaster (for example, a hurricane, flood, fire, tornado, earthquake, Yes No 
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or explosion)? 
c
 
51. …being threatened by criminals or terrorists?
 c
 Yes No 
52. 
…being a victim of a crime (for example, being robbed, assaulted, or 
mugged)?
 c
 
Yes No 
53. …being in a war zone?
 c
  Yes No 
54. …being imprisoned, kidnapped, tortured, or held hostage?
 c
 Yes No 
 
55. Are there any other upsetting events that happened to you that I haven’t 
asked you about?   What were they? 
Record here: 
 
 
 
Yes No 
56. 
Did you ever witness any upsetting events, like the ones we’ve been 
talking about, that happened to someone else?
 c
 
Yes No 
57. 
Did you ever hear about any upsetting events like these happening to 
someone else, so that you felt very affected by them? 
Yes No 
58. Are there periods of time in your life after the age of 5 about which you 
can remember absolutely nothing?        
Yes No 
 
 
DOMAIN IV.  REACTION TO LOSSES OR UPSETTING EVENTS 
 
Note to interviewer: Before proceeding, make a note of the losses and events endorsed by 
the subject so you can refer to these during the rest of the interview.  If the subject has not 
endorsed any losses or events up to this point, skip to Domain IX (Personal 
Characteristics). 
 
Did this event or loss make you feel extremely… 
59. …afraid? Yes No 
60. …sad? Yes No 
61. …guilty or ashamed? Yes No 
62. …bitter or angry? Yes No 
63. …hopeless or helpless? Yes No 
64. …horrified or disgusted? Yes No 
65. …physically or emotionally numb or paralyzed? Yes No 
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At the time of the loss or event, did you have any of the following… 
66. …pounding heart, sweating, trembling, or shaking? Yes No 
67. …sensations of shortness of breath or choking?  Yes No 
68. …chest discomfort or pain? Yes No 
69. …nausea or abdominal distress? Yes No 
70. …feeling dizzy, unsteady, light-headed, or faint? Yes No 
 
At the time of the loss or event, did you feel… 
71. 
...like the event wasn’t real, or as if you were in a dream or like you were 
a spectator? 
Yes No 
72. ...you were doing things automatically, without thinking about them? Yes No 
73. 
...your sense of time changed, for example, things seemed to be 
happening in slow motion? 
Yes No 
74. ...confused or uncertain about where you were or what time it was? Yes No 
75. ...that colors, sounds and smells were unusually vivid or unbearable? Yes No 
76. ...exceptionally alert or clear-headed? Yes No 
 
DOMAIN V. RE-EXPERIENCING 
 
Since the loss or event, have you ever… 
77. 
…had recurrent bad dreams or nightmares about the loss or event, or 
awakened terrified?  
Yes No 
78. 
…suddenly gotten bad feelings when you were around certain places, 
odours, sounds or people?  
Yes No 
79. …felt or acted as if the events were happening again?  Yes No 
80. …had distressing thoughts, feelings, or images related to the loss or event? Yes No 
81. 
…become more distressed at the time of year when the loss or event 
occurred?  
Yes No 
 
82. 
Did you notice that other people avoided talking about the loss or event 
because you got so upset? 
Yes No 
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When thinking about the loss or event, did you ever…  
83. 
...feel upset or have waves of emotion or a sinking feeling in the pit of your 
stomach? 
Yes No 
84. 
...have other physical sensations, such as pain, palpitations, sweating, 
headache, etc.? 
Yes No 
85. …feel guilt or shame or blame yourself for what happened? Yes No 
 
DOMAIN VI.  AVOIDANCE & NUMBING 
 
Did you ever avoid…    
86. ...thinking or talking about the loss or event?  Yes No 
87. 
...specific places, people, or social situations that reminded you of the loss 
or event?  
Yes No 
88. 
…reading the newspaper or watching certain TV programs or movies 
because they reminded you of the loss or event?  
Yes No 
89. 
…activities or things that evoked feelings of loneliness, crying or other 
distressing emotions related to the loss or event?  
Yes No 
 
Since the loss or event, did you ever… 
90. 
…find that you were unable to remember things connected to the loss or 
event? 
Yes No 
91. 
…find that certain activities or things became pointless, meaningless or 
insignificant? 
Yes No 
92. 
…feel that you no longer had emotions you used to have, or that your 
feelings were dulled? 
Yes No 
93. ...feel cut-off or detached, or like you were different from other people? Yes No 
94. 
…have difficulty trusting people, either strangers, people in your family, 
or your friends?   
Yes No 
95. …feel that you wouldn’t live a long or satisfying life? Yes No 
96. 
…feel as if your life was changed forever and things would never be the 
same? 
Yes No 
97. …feel as if your personality changed? Yes No 
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DOMAIN VII.  MALADAPTIVE COPING 
 
Since the loss or event, did you ever…  
98. 
…stop taking care of yourself, for example, not getting enough rest or not 
eating right? 
Yes No 
99. 
…stop taking prescribed medications or fail to follow-up with medical 
recommendations, such as appointments, diagnostic tests, or a diet? 
Yes No 
100. 
… use alcohol or drugs or over-the-counter medications to calm yourself 
or to relieve emotional or physical pain? 
Yes No 
101. 
...engage in risk-taking behaviours, such as driving fast, promiscuous sex, 
hanging out in dangerous neighbourhoods? 
Yes No 
102. …wish you hadn’t survived?  Yes No 
103. …think about ending your life? Yes No 
104. ...intentionally scratch, cut, burn or hurt yourself? Yes No 
105. …attempt suicide? Yes No 
     
DOMAIN VIII.  AROUSAL 
 
Since the loss or event, did you ever… 
106. 
…have trouble concentrating or paying attention, for example, following 
the story line of a TV program or book or remembering what you had read? 
Yes No 
107. …feel like you just couldn’t relax or let your guard down? Yes No 
108. 
…startle easily at the sound of sudden noises, or when someone touched 
you, spoke to you, or approached you unexpectedly? 
Yes No 
109. 
…feel more irritable, have outbursts of anger or rage, or lose your temper 
over minor things?  
Yes No 
110. 
…have more difficulty falling asleep or staying asleep than before or need a 
light on to go to sleep? 
Yes No 
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DOMAIN IX. Personal Characteristics/Risk Factors 
 
Now I’m going to ask you some questions about how you are now. 
Are you the type of person or have others told you that you… 
111. …are extremely sensitive to stress or loss? Yes No 
112. …are provocative? Yes No 
113. …like being the centre of attention? Yes No 
114. 
…often follow your instinct without really thinking about what you are 
doing? 
Yes No 
115. …usually find exciting what others would find frightening? Yes No 
116. …often engage in reckless or dangerous activities? Yes No 
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